Bioanalytical solutions to characterize human proteome of clinical interest: healthy newborns and their early infections by Tigli, Laura
  
UNIVERSITÀ DEGLI STUDI DI PARMA 
 
 
 
Dottorato di ricerca in Biochimica e Biologia Molecolare 
 
XXVI ciclo: 2011 – 2013 
 
 
 
 
 
 
 
 
Bioanalytical solutions to characterize 
human proteome of clinical interest: 
healthy newborns and their early infections 
 
 
 
 
 
 
 
 
 
 
 
Coordinatore: 
Chiar.mo Prof. Andrea Mozzarelli 
 
 
Tutor: 
Dott.ssa Barbara Pioselli 
 
Dottoranda: Laura Tigli 
  
 
 
 
 I 
 
SUMMARY 1 
1. INTRODUCTION 3 
1.1. SALIVA 4 
Whole saliva 4 
Production of saliva 4 
Saliva as a diagnostic fluid 5 
1.2. ACUTE INFLAMMATION 7 
The acute-phase response 7 
Acute-phase proteins 8 
Calcitonin (CT) 8 
Procalcitonin (PCT) 10 
C-reactive protein (CRP) 10 
1.3. BOTTOM-UP PROTEOMICS 12 
Protein digestion 12 
Gel-based approaches 15 
Two-Dimensional Electrophoresis analysis (2-DE) 15 
1.4. MASS SPECTROMETRY 21 
Soft ionization sources 22 
MALDI 22 
ESI 25 
Mass analyzers 27 
Time-of-flight (TOF) 28 
Quadrupole (Q) 30 
Quadrupole ion trap (QIT) 31 
Quadrupole linear ion trap (LIT or LTQ) 32 
Orbitrap (OT) 35 
Ion mobility spectrometer (IMS) 36 
Tandem mass spectrometry 40 
Peptide fragmentation 41 
2. AIM OF THE WORK 43 
3. RESULTS 45 
3.1. UNTARGETED GEL-BASED APPROACHES 46 
2-DE – MALDI-TOF/TOF 47 
Single newborn analyses 47 
Pool analyses 48 
SDS-PAGE – LC-(HR)MS/MS 55 
  
II 
 
3.2. TARGETED ANALYSES 57 
Targeted analyses in aqueous solution 59 
Human calcitonin 59 
Human procalcitonin 72 
Human C-reactive protein 76 
Targeted analyses in organic-aqueous solution 87 
Human calcitonin 87 
Human procalcitonin 97 
Human C-reactive protein 103 
3.3. ANALYSIS OF PEPTIDES 115 
3.4. CHOICE OF THE STATIONARY PHASE 116 
3.5. ANALYSIS OF THE MATRIX EFFECT 118 
4. DISCUSSION 121 
4.1. GEL-BASED APPROACHES 122 
4.2. TARGETED ANALYSIS 124 
Sample preparation 124 
Digestions in aqueous solution 125 
Digestions in mixed organic-aqueous solvent systems 126 
Characteristics of the peptides 128 
Evaluation of stationary and mobile phases 128 
MS/MS analyses 133 
Calibration curves 134 
Analysis of the matrix effect 136 
5. CONCLUSIONS 137 
6. EXPERIMENTAL SECTION 139 
6.1. GEL-BASED APPROACHES 140 
Reagents and tools 140 
Collection of biological samples 143 
Extraction of proteins from swabs 144 
Extraction of proteins from swabs 144 
Quantitation of the extracted protein amount 144 
2-DE – MALDI-TOF/TOF analyses 145 
Single newborn analyses 145 
2-DE analyses of pools 145 
Visualization of proteins 146 
Spot excision and tryptic digestion 146 
MALDI-TOF/TOF analyses 147 
  
III 
 
SDS-PAGE – LC-(HR)MS/MS analyses 149 
SDS-PAGE analysis 149 
Band excision and tryptic digestion 149 
LC-(HR)MS/MS analyses 149 
6.2. TARGETED ANALYSES 151 
Reagents and tools 151 
Purification procedures 154 
Reverse-phase chromatography 154 
Size exclusion chromatography 155 
Others 156 
MALDI-TOF/TOF 157 
HPLC – Q TRAP 159 
Analyses of protein standards digested in aqueous solution 159 
Analyses of protein standards digested in organic-aqueous solutions 160 
UPLC – SYNAPT 162 
MRM analyses 163 
Protein standards digested in aqueous solution 163 
Protein standards digested in mixed organic-aqueous solvent system 165 
Collection of biological samples 167 
Sample preparation and LC-MS/MS analysis 168 
Extraction of proteins from swabs and creation of a pooled sample 168 
Quantitation of the extracted protein amount 168 
Digestion of the pooled sample for LC-MS/MS analysis 168 
Digestion of the protein standards in organic-aqueous solution 168 
MRM analyses 169 
BIBLIOGRAPHY 171 
 
 
 
 
  
  
IV 
 
 
 
Summary 
1 
 
SUMMARY 
Early-onset sepsis (EOS), defined as a septic state manifested in the first three days of life, is one of the 
major causes of neonatal mortality and surviving infants are at increased risk for developing morbidities. 
Since the traditional methods for the diagnosis of sepsis (i.e. cultures of blood, urine, cerebrospinal fluid 
or bronchial fluid specimens) usually take 24 to 48 hours and clinical symptoms frequently manifest 
themselves in the absence of a positive culture, a faster and more unequivocal test for the differential 
diagnosis of infection and sepsis is needed. The main aim of the project was the investigation of saliva as 
a biological fluid reporting on health status of newborns, followed by the development of an innovative 
and noninvasive diagnostic method to differentiate bacterial from noninfectious causes of inflammation. 
2-DE – MALDI-TOF/TOF and 1-DE – LC-(HR)MS/MS untargeted gel-based approaches were exploited 
for the characterization of the protein composition of whole saliva samples collected from healthy 
newborns within 48 hours after birth. The two approaches proved to be useful in providing 
complementary information: 2-DE was focused on the pH range 4 – 7 and most of the identified proteins 
have MW < 40 kDa, whereas 1-DE – LC-(HR)MS/MS analyses allowed to identify a number of proteins 
featuring basic pI and/or high molecular weight. As a whole, the gel-based analyses led so far, not 
surprisingly, to the identification of a number of proteins linked to epidermal tissue functions and, more 
interestingly, of a number of proteins usually highly expressed and involved in inflammatory processes, 
including annexin A1, glutathione S-transferase P, heat shock proteins, protein S100-A8 and -A9, 
probable evidence of a stressed condition especially in the early 24 hours after birth. As soon as enough 
samples collected from newborns affected by bacterial infection will be available, a comparison will be 
performed to highlight the overall alteration of physiological protein pattern as well as over- or under-
expressed proteins. This will give new inputs to the development of innovative and noninvasive 
diagnostic methods for the early detection of EOS. 
In parallel with the identification of a specific target protein (or a pattern of target proteins) through the 
gel-based discovery approach, targeted analyses were carried out with the aim of developing an analytical 
method based on liquid chromatography coupled to mass spectrometry to qualitatively and quantitatively 
assay C-reactive protein, calcitonin and its precursor procalcitonin, acute-phase proteins widely 
considered plasmatic markers of sepsis, within salivary samples. Different sample preparation conditions 
were tested for each of the above-mentioned proteins and MALDI-TOF-based peptide mapping was 
exploited to compare a classical workflow of digestion in aqueous solution with the more recently 
described digestion in mixed organic-aqueous solution. In both cases, proteotypic peptides were identified 
and an optimization of the chromatographic and mass spectrometric conditions for their quantification on 
a Q TRAP instrument operated in MRM mode was performed. The developed methods allowed to detect 
the proteins of interest in the low µg/ml range. However, preliminary experiments on salivary samples 
showed the presence of matrix effects that need to be further investigated. Whenever possible, MS
E
 
experiments on Synapt G2-S were carried out to evaluate the applicability of a similar platform to high-
throughput screening of the proteins of interest and their post-translational modifications within 
biological samples. 
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1.1. SALIVA 
WHOLE SALIVA 
Whole saliva is a complex mixture found in the oral cavity mainly constituted by: 
 the exocrine secretions of the three pairs of major salivary glands (parotid, submandibular and 
sublingual) (Figure 1-1) and the minor salivary glands (located throughout the oral cavity); 
 the gingival crevice fluid (mixture of substances derived from blood); 
 the transudate of the oral mucosa; 
 mucous of the nasal cavity and the pharynx; 
 desquamated epithelial and blood cells; 
 non-adherent oral bacteria; 
 as well as potential food residues and traces of other exogenous compounds (drugs, smoke 
residues and tooth paste) [1-3]. 
 
 
Figure 1-1. Location of the major salivary glands (parotid, submandibular and 
sublingual). From http://www.salimetrics.com 
PRODUCTION OF SALIVA 
Saliva produced by the salivary glands (Figure 1-2) consists approximately of 99% water and might also 
contain: 
 a variety of electrolytes: sodium, potassium, calcium, chloride, magnesium, bicarbonate, 
phosphate; 
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 proteins and oligopeptides: enzymes, immunoglobulins and other antimicrobial factors, mucosal 
glycoproteins, albumin; 
 nucleic acids; 
 hormones: estradiol, progesterone, testosterone, DHEA, cortisol; 
 glucose; 
 nitrogenous products, such as urea and ammonia [1, 3]. 
 
 
Figure 1-2. Scheme of a salivary gland. The primary secretion produced by the serous, mucous or mixed 
seromucous acini is further modified in the excretory ducts to produce saliva. Solid black arrows indicate the 
direction of transport of salivary components and the white arrow indicates the direction of salivary flow. 
Modified from Standring [4]. 
SALIVA AS A DIAGNOSTIC FLUID 
Most of the organic compounds in whole saliva are hence produced locally by the salivary glands, but 
some molecules pass into saliva from blood. The transfer of biomolecules from blood into saliva can 
follow different pathways: diffusion, active transport, ultrafiltration, transudation from either the gingival 
crevicular fluid or the oral mucosa. This connection between saliva and blood makes saliva a potential 
diagnostic fluid that presents significant advantages over serum: 
 easiness of sample collection; 
 non-invasive collection procedure, well tolerated by patients; 
 minimal risk of transmission of infections [1, 5-7]. 
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Potential clinical applications are represented by: 
 screening for oral and systemic diseases; 
 treatment/outcome monitoring; 
 environmental exposure monitoring. 
Interest in saliva has increased over the past decade since it is widely accepted that it reflects oral and 
body’s health status in a number of pathological conditions (HIV, cardiovascular disease, Sjögren’s 
syndrome, cystic fibrosis, periodontitis, oral squamous cell carcinoma and others) [5, 8-11]. Nevertheless 
the lack of a deep knowledge of the biomolecules present in this complex fluid and the lack of 
understanding of their relevance in relationship to specific diseases, combined with the lack of high-
sensitivity detection methods, are the major obstacles that frequently hinder its use as a diagnostic 
medium. 
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1.2. ACUTE INFLAMMATION 
THE ACUTE-PHASE RESPONSE 
The acute-phase response (APR) is the complex series of events, initiated in response to inflammatory 
stimuli (infection, injury or physical trauma), which aim to prevent tissue damage and restore the 
homeostasis of the organism (Figure 1-3) [12]. 
 
Figure 1-3. Scheme of the series of events triggered by an inflammatory stimulus. From Becker et al. [12]. 
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The clinical signs of an ongoing acute-phase response are fever, alterations in the metabolism of many 
organs, leukocytosis and changes in the plasmatic concentrations of various proteins, known as the acute-
phase proteins. 
ACUTE-PHASE PROTEINS 
Acute-phase proteins (APP) are those proteins whose plasmatic concentration varies by at least 25% 
during an acute-phase response in respect to the physiological values. Generally their concentration 
increases and therefore they are termed “positive” (e.g.: C-reactive protein, serum amyloid A, fibrinogen, 
complement factors, α-1-antitrypsin and many others), but there are also “negative” acute-phase proteins 
whose concentration decreases (e.g.: albumin, transferrin, transtyretin, antithrombin). The expression of 
the positive APPs is stimulated by cytokines, such as interleukins 1β, 6 and 8 (IL-1β, IL-6, IL-8), tumor 
necrosis factor α (TNF-α) and transforming growth factor β (TGF-β), which are released into the 
bloodstream by inflammatory cells. Positive acute-phase proteins are involved in different functions of 
the innate immunity [13, 14]. 
Upon infections of bacterial origin, circulating levels of C-reactive protein (CRP) and calcitonin 
precursors (CTpr), including procalcitonin (PCT), increase several thousand-fold (Figure 1-4). Moreover, 
this increase often correlates with the severity of the clinical condition and patient prognosis [15]. 
Therefore, measurement of acute-phase proteins in biological fluids is useful for the early diagnosis of 
infection and therapy monitoring [12, 16-19]. 
 
 
Figure 1-4. Diagram illustrating the response to one injection of endotoxin in human 
volunteers. Kinetics of some humoral markers of illness: tumor necrosis factor (TNF-α), interleukin-
1 receptor antagonist (IL-1ra), interleukin-6 (IL-6), calcitonin precursors (CTpr) and C-reactive 
protein (CRP). From Becker et al. [12]. 
 
Calcitonin (CT) 
Calcitonin is a peptide hormone constituted by 32 amino acids organized to form a single α-helix (Figure 
1-5). 
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Figure 1-5. Cartoon of calcitonin structure. PDB code 2jxz. 
 
CT is synthesized in thyroidal C-cells from pre-procalcitonin, a product of the expression of the CALC-1 
gene, via a series of proteolytic cleavages. The immature form consists of 33 amino acids, ending with a 
glycine, which is finally cut by a protease to produce the mature form of the calcitonin peptide (Figure 
1-6) [20]. 
 
 
Figure 1-6. Synthesis of calcitonin in thyroidal C-cells. The synthetic pathway of human calcitonin is 
shown in blue. Pre-procalcitonin is a product of the expression of the CALC-1 gene. The N-terminal 
signalling sequence of pre-procalcitonin allows binding to the endoplasmic reticulum and cleavage by an 
endopeptidase to produce procalcitonin. Inside the C-cell, procalcitonin is cleaved into the three immature 
forms of N-ProCT, calcitonin and katacalcin. The immature calcitonin is further processed by an amino- and 
a carboxy- peptidase to produce the 32 amino acid peptide, which is amidated at the Pro32 by a peptidyl 
glycine amidating mono-oxygenase. N-ProCT = N-Procalcitonin, hCT = human Calcitonin, KAT = 
Katacalcin, EP = Endopeptidase, PC = Prohormone Convertase, CP = Carboxypeptidase, AP = 
Aminopeptidase, PAM = Peptidyl Glycine Amidating Mono-oxygenase. Modified from Maruna et al. [20]. 
 
Human CT presents two post-translational modifications: a disulfide bond between Cys residues 1 and 7 
and an amidated proline at the C-terminus (residue 32). Both the N-terminal ring structure created by the 
disulfide bond and the post-translational amidation of Pro32 are essential for the full expression of the 
known functions of calcitonin. Calcitonin is a peptide hormone physiologically involved in the 
metabolism of calcium ions. It causes a rapid but short-lived drop in the levels of calcium and phosphate 
in blood by promoting their incorporation in the bones [12]. 
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Procalcitonin (PCT) 
Procalcitonin (PCT) is a protein composed by 116 amino acids (13 kDa), encoded by the CALC-1 gene. 
Cleavage of the primary transcript of the CALC-1 gene produces pre-PCT, which in turn undergoes 
further cleavage of an N-terminal signal sequence to produce PCT [21]. 
Procalcitonin is composed of three portions: the N-terminus (N-proPCT), the immature calcitonin (CT) 
and calcitonin carboxypeptide-1 (CCP-1, also known as katacalcin) (Figure 1-7). Known post 
translational modifications include a disulfide bond between Cys residues 60 and 66, glycosylation at a 
site located between the Cys residues, deamidation and enzymatic cleavage into the 3 – 116 amino acid 
protein [21]. 
 
 
Figure 1-7. Scheme of procalcitonin synthesis from preprocalcitonin. EP = 
endopeptidase, PCT = procalcitonin, CT = calcitonin, CCP-1 = calcitonin carboxypeptide-1 
(katacalcin). Modified from Jin et al. [16]. 
 
In healthy individuals PCT is physiologically expressed in thyroidal C-cells and post-translationally 
modified to produce calcitonin. In the presence of bacterial infection, PCT is expressed also in extra-
thyroidal tissues (lung, liver, kidney, pancreas, adipose tissue, white blood cells), which lack the enzymes 
responsible for the post-translational modifications. Thus, high plasmatic levels of PCT and not CT are 
found in infected patients [15]. 
PCT expression appears to be stimulated both directly, via bacterial toxins, and indirectly, via 
inflammatory mediators such as IL-1, IL-6 and TNF-α. However, the functions of PCT synthetized in 
non-neuroendocrine tissues are still unclear. Current hypotheses point to a role of PCT in the 
neutralization of lipopolysaccharide molecules, in the modulation of NO synthesis and in pain-relieving 
mechanisms [12, 20-22]. 
C-reactive protein (CRP) 
The product of the CRP gene is a protein of 224 amino acids (Figure 1-8), further processed into the 
mature form by cleavage of the signal peptide 1-18 [23]. 
CRP is a pentaxin, that is a protein composed of five identical protomers non-covalently associated and 
arranged symmetrically around a central pore (Figure 1-9). Each protomer consists of 206 amino acids 
(23 kDa) and is folded into two antiparallel β sheets with a flattened jellyroll shape. Since all the five 
protomers have the same orientation, the CRP pentamer has essentially two faces. On one side there are 
the recognition sites for phosphocholine (PCh), with a binding site on each protomer consisting of two 
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coordinated calcium ions adjacent to a hydrophobic pocket. On the opposite side of the CRP pentamer 
there is the effector site, involved in the binding of complement C1q and Fcγ receptors [14, 23-25]. 
Known post translational modifications include a disulfide bond between the two Cys residues 54 and 
115 and the cyclization of the N-terminal glutamine forming the pyrrolidone carboxylic acid. 
 
 
Figure 1-8. Secondary structure of CRP. From http://www.uniprot.org/uniprot/P02741 
 
 
Figure 1-9. Cartoon of CRP structure. From Black et al. [23]. 
 
CRP owes its name to its ability to precipitate pneumococcal C-polysaccharide in the presence of calcium 
ions. CRP binds to phosphocholine and to a variety of other ligands, including phosphoethanolamine, 
chromatin, histones, fibronecting, small nuclear ribonucleoproteins, laminin and polycations. The main 
physiologic function of CRP is to recognize bacteria and damaged or apoptotic cells of the host and to 
mediate their elimination by recruiting the complement system and phagocytic cells. Ligand-bound CRP 
activates the classical complement pathway through direct interaction with C1q [23-25]. 
CRP is mainly synthetized by the liver during the acute phase response. IL-6 is the principal inducer of 
the CRP gene while IL-1, glucocorticoids and some other factors including complement activation 
products, act synergistically with IL-6 to enhance its effect. CRP concentrations rise within 12 hours and 
reach peak levels between 24 and 48 hours with a 1000-fold increase. CRP levels decline quite rapidly 
because its relatively short half-life of 18 hours [25]. Since rapid and marked increases in CRP 
concentrations occur in a variety of conditions (inflammation, infection, trauma, malignancies, and 
autoimmune disorders) CRP doesn’t diagnose any specific disease. 
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1.3. BOTTOM-UP PROTEOMICS 
Bottom-up proteomics is a well-known and widely used approach for protein identification and 
characterization. The two main bottom-up strategies, peptide mass fingerprinting (PMF) and peptide 
fragment fingerprinting (PFF), consist respectively on the acquisition of MS and MS/MS data of peptides 
originated by proteolytic cleavage with a specific enzyme. Peptides may be originated by digestion of 
single proteins (isolated by 2-DE approach or liquid chromatography) or by digestion of a complex 
mixture (“shotgun proteomics”) (Figure 1-10). 
 
 
Figure 1-10. Scheme of the bottom-up and top-down strategies for protein identification and 
characterization. From Han et al. [26]. 
 
Protein digestion 
As previously mentioned, the key steps in bottom-up proteomics are protein digestion with proteases 
followed by mass spectrometric analysis. Trypsin is the most commonly used protease since it has a well-
defined specificity: the peptide bonds are cleaved at the carboxyl side of lysine (Lys) and arginine (Arg) 
residues. The hydrolytic reaction is less likely to occur when Lys and Arg are followed by a proline and 
when an acidic residue is on either side of the cleavage site [27]. 
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Trypsin shares the same mechanism of serine proteases (Figure 1-11 and Figure 1-12) [28]. 
 
 
Figure 1-11. Scheme of trypsin active site. The catalytic triad is constituted by a serine 
(Ser), a histidine (His) and an aspartate (Asp). From Berg et al. [28]. 
 
 
Figure 1-12. Scheme of the catalytic mechanism of serine proteases. The reaction proceeds through eight steps: 
(1) substrate binding, (2) nucleophilic attack of serine alkoxyde ion on the peptide carbonyl group, (3) collapse of 
the tetrahedral intermediate, (4) release of the amine component, (5) water binding, (6) nucleophilic attack of water 
on the acyl-enzyme intermediate, (7) collapse of the tetrahedral intermediate, (8) release of the carboxylic acid 
component. Modified from Berg et al. [28]. 
 
The main variables to be considered when performing a tryptic digestion experiment are: 
 pH: the optimal range is 7.5 – 8.5; 
 temperature: trypsin has a maximum activity at 37 °C; 
 enzyme to protein ratio: it is usually recommended between 1:20 and 1:100; 
 time: the optimal duration of the reaction has to be evaluated as it depends on the enzyme to 
substrate ratio and on the type of reaction buffer. 
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It has been shown that trypsin maintains its proteolytic activity and specificity in a variety of mixed 
organic-aqueous solvent systems, such as methanol–water, acetonitrile–water, 2-propanol–water, or 
acetone–water, even at high concentrations of organic solvent (60 – 80%) [29-31]. The main features of 
proteolysis in mixed organic-aqueous solution, compared to proteolysis in aqueous solution, are: 
 high efficiency in terms of both rate of digestion and amino acid sequence coverage, probably due 
to the retention of activity of trypsin combined to the increased solvation and conformational 
changes of substrate proteins; 
 tendency to produce a high number of peptides containing missed cleavages. 
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GEL-BASED APPROACHES 
Mono-dimensional (1D-PAGE) and two-dimensional (2-DE) gel electrophoresis are gel-based separation 
techniques in bottom-up proteomics. Gel-based approaches feature some advantages and some 
drawbacks. Added information is available regarding the molecular weight (1D-PAGE) or both molecular 
weight and isoelectric point (2-DE) of the protein(s) prior to proteolysis. Furthermore, some post-
translational modifications can be easily visualized on 2-DE gels. For example multiple phosphorylation 
states of a single protein appear as multiple spots on the same horizontal row since those molecules share 
nearly the same molecular weight but their isoelectric points differ. However gel-based approaches are 
time-consuming and labor-intensive, although a certain degree of automation is possible. 
 
Two-Dimensional Electrophoresis analysis (2-DE) 
Two-dimensional electrophoresis (2-DE) is a method for the analysis of complex protein mixtures which 
sorts proteins through two orthogonal separative dimensions: in the first dimension, isoelectric focusing 
(IEF), proteins are separated according to their isoelectric point (pI), and then in the second dimension, 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE), proteins having the same pI are 
separated according to their molecular weight (Figure 1-13). 
 
Figure 1-13. Scheme of the two orthogonal dimensions in 2-DE. After sample preparation proteins are 
loaded onto the IPG strip (rehydration loading in the picture) and separated according to their pI in the 
first dimension (IEF). The co-focalized proteins are then separated in the second dimension (SDS-PAGE) 
according to their molecular weight. 
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A 2-DE analysis goes through a number of steps that will be briefly discussed hereinafter [1, 10]. 
 
 
1. Protein sample preparation 
The sample preparation step is a key to the success of the whole 2-DE experiment and strongly 
depends on the aim of the research. The optimal preparation is to be determined empirically. Features 
of the proteins of interest, such as the solubility, size, charge, and isoelectric point, have an impact on 
sample preparation. Sample preparation can also help to reduce the complexity of a protein mixture 
when the interest is focused only on a subset of the proteins in the sample. 
 
2. IPG strip rehydration 
Rehydration solutions generally contain: 
 a denaturant agent (urea and thiourea) that solubilizes and denatures proteins; 
 a non-ionic or zwitterionic detergent (CHAPS, Triton X-100, octyl-glucoside) that helps to 
solubilize hydrophobic proteins and minimizes protein aggregation; 
 a reducing agent (dithiothreitol, dithioerythritol, trybutylphosphine) to cleave disulphide bonds 
and maintain all proteins in their fully reduced state; 
 an ampholyte mixture, appropriate to the pH range of the IPG strip, to enhance sample 
solubility by minimizing protein aggregation due to charge-charge interactions and to improve 
conductivity across the immobilized pH gradient; 
 a tracking dye (bromophenol blue) to monitor the beginning of the IEF protocol. 
Rehydration solution may or may not include the sample. 
 
3. Sample loading 
Basically there are two methods to load a sample onto an IPG strip for analytical analyses: 
 Rehydration loading. 
Sample is included in the rehydration solution. As the strip rehydrates, proteins in the sample 
are absorbed and distributed over the entire length of the strip. This method is the most 
commonly exploited since it carries some advantages: the general procedure is easy and it is 
suitable for loading not only large quantities of proteins but also diluted samples. There are two 
rehydration methods: 
 Passive rehydration. 
No electric field is applied during the rehydration step. 
 Active rehydration. 
A low voltage is applied (usually 20 – 120 V) to facilitate the entry into the strip of 
proteins featuring high molecular weights. 
 Cup loading. 
This method usually gives better results in analyses at basic pH ranges. Sample is applied via a 
sample cup at the anodic side of a previously rehydrated IPG strip. The limits of this procedure 
include the risk of formation of precipitates at the application point and problems of leakage. 
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4. IEF (first dimension) 
The net charge of a protein is the sum of all the negative and positive charges of the side chains of its 
residues and the amino- and carboxyl- termini. The net charge can be positive, negative or equal to 
zero depending on the pH of the environment. The isoelectric point (pI) of a protein is the specific pH 
at which the net charge of the protein is zero. At pH values below its pI the protein carries a positive 
net charge, while at pH values above its pI the protein carries a negative net charge (Figure 1-14). 
 
 
Figure 1-14. Plot of the net charge of an hypothetical protein versus the pH of 
the environment. The intercept with the x-axis, that is the pH at which the net 
charge is zero, represents the pI of the protein. 
 
The first dimension in 2-DE is represented by isoelectric focusing (IEF) which is an electrophoretic 
method to separate proteins according to their isoelectric point (pI): each protein migrates through an 
immobilized pH gradient (IPG) under the influence of an electric field until its net charge becomes 
zero. 
IPG strips are commercially available in a variety of pH ranges and lengths ( 
Figure 1-15.). The degree of resolution of the IEF separation is determined by a series of factors, 
including the slope of the pH gradient, the electric field strength applied and the length of the IPG 
strip. 
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Figure 1-15. Example of IPG strips commercially available. From BIO-RAD catalogue. 
 
A typical IEF protocol generally proceeds through a series of steps. The main steps can be 
summarized as follows: 
I. a low-voltage step to initiate desalting of the sample; 
II. a progressive gradient to high voltage to mobilize the ions; 
III. a high-voltage step to complete the isoelectric focusing: this step is generally performed 
through the application of a constant number of Volt-hours (Vh), with Vh being the integral 
of the Volts applied over the separation time; 
IV. a low-voltage step to keep the proteins focalized. 
 
Three processes mainly contribute to mass transfer in isoelectric focusing: 
a) electrical migration of charged species: the establishment of a voltage gradient between 
two electrodes causes mass transfer between them; 
b) diffusion: species move under a chemical potential gradient (e. g.: concentration gradient); 
c) convection, which occurs as a result of diffusion or hydrodynamic transport (e. g.: 
electroendosmotic movement). 
Those three mass transfer processes contribute to the net observable electrical current (I), which 
follows Ohm’s law V = I • R, where V is the voltage and R the resistance. The moving current is due 
to both ionic species, which move towards the oppositely charged electrode, and amphoteric 
molecules, that move under the influence of the electric field until they reach their steady state 
position in the IPG. The equilibrium current is the current generated by all the species as they diffuse 
around their equilibrium position. Therefore at constant voltage, the contribution of the moving 
current to the net current progressively decreases with time, whereas the equilibrium current is 
linearly proportional to the voltage. 
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5. Equilibration step 
Proteins co-focalized at a given pI in the first dimension are prepared to be separated in the second 
dimension according to their molecular weight. The equilibration step usually consists of two phases: 
 at first the IPG strip is incubated in SDS-PAGE running buffer (50 mM Tris-HCl, pH 8.8) 
containing urea, SDS, glycerol, DTT, tracking dye (bromophenol blue): 
o urea reduces electroendosmosis effects; 
o SDS denatures proteins; 
o glycerol both helps reducing electroendosmosis effects and improves transfer of 
proteins from the IPG strip to the SDS-PAGE gel; 
o DTT keeps the Cys residues in their reduced state; 
o bromophenol blue allows the monitoring of the electrophoresis; 
 then iodoacetamide is added to alkylate sulfhydryl groups and thus prevent their 
oxidation during electrophoresis. 
 
6. SDS-PAGE 
In the second dimension (SDS-PAGE), proteins are separated according to their molecular weight 
(MW) in a polyacrylamide gel containing SDS. SDS is an anionic detergent that denatures proteins 
and wraps around their backbone at a constant ratio (1.4 g of SDS per 1 g of protein). Therefore the 
intrinsic electrical charge of the proteins in the sample does not influence their mobility in the gel 
since the anionic complexes formed carry a constant net negative charge per unit of mass. 
Various types of polyacrylamide gel can be produced (Table 1-1): 
 single percentage gels, which offer better resolution in a particular range of molecular 
weights. The most common is the 12%. 
 gradient gels, which generally offer wider separation windows. 
 
Table 1-1. Relationship between acrylamide concentrations 
and allowed separation ranges. From Berkelman et al. [32]. 
 
 
The most commonly used running buffers for SDS-PAGE are the Tris-Glycine Laemmli buffer and 
the Tris-Tricine buffer, with the latter being preferred when better resolution at low molecular 
weights (below 10 kDa) is required. 
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7. Visualization of proteins: staining methods 
 Coomassie staining. 
The colloidal form of Coomassie dye (Figure 1-16), formulated in acidic buffer, binds to 
proteins through ionic interactions between the sulfonic acid groups and basic residues 
(arginine, lysine and histidine), but also Van der Waals forces and hydrophobic interactions 
are involved. The binding causes a spectral shift from the reddish-brown to the blue form of 
the dye. The difference between the two forms of the dye has its maximum at λ = 595 nm, 
which is therefore the optimal wavelength to measure the absorbance of the protein-dye 
complex. 
 
 
Figure 1-16. Chemical structure of Coomassie Brilliant Blue G-250 dye. 
 
Advantages: simpler and more quantitative than silver staining. Limits: about 50-fold less 
sensitive than silver staining, incompatible with surfactants. 
 Silver staining. 
This is the most sensitive staining technique (sub ng). Basically the procedure consists in the 
deposition of metallic silver in correspondence of protein bands or spots in the gel. Silver ions 
of a silver nitrate solution interact and bind to certain protein functional groups. The strongest 
interactions occur with carboxylic acid groups (aspartate and glutamate), imidazoles 
(histidine), sulfhydryls (cysteine) and amines (lysine). Sensitizers and enhancers are used in 
the procedure to control the specificity and efficiency of the binding and the following 
reduction to metallic silver (staining development). Limits: complex and multistep process, 
high-purity reagents and precise timing are required for high-quality and reproducible results. 
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1.4. MASS SPECTROMETRY 
Mass spectrometry is basically a two-step technique: it requires at first the ionization of the analyte and 
then the determination of its mass-to-charge ratio (m/z). Therefore, a mass spectrometer is essentially 
composed of two distinct parts: the ion source, the place where ionization and desolvation of the analytes 
actually take place, and the analyzer, where the ions are separated and their m/z ratio is measured (Figure 
1-17). 
 
 
Figure 1-17. Scheme of the main components of a mass spectrometer: a sample introduction device, the 
ion source, the analyzer and the detector. As will be discussed later on, the traditional ionization sources for 
proteomics research are MALDI (Matrix-Assisted Laser Desorption/Ionization) and ESI (ElectroSpray 
Ionization). Different types of analyzers exist, some of which are usually employed with MALDI ion 
sources (e.g. TOF) and some others are normally coupled to ESI ion sources (e.g. ion traps or quadrupoles). 
From Cañas et al. [33]. 
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SOFT IONIZATION SOURCES 
The primary methods of choice for the ionization of large non-volatile and thermally labile molecules are 
matrix-assisted laser desorption/ionization (MALDI) and electrospray ionization (ESI). 
 
MALDI 
Introduced in 1988 principally by Karas and Hillenkamp, MALDI is suitable for mass spectrometric 
analysis of large, non-volatile and thermally-labile biomolecules such as proteins, oligonucleotides and 
synthetic polymers. 
Typical MALDI analyses essentially require the mixing of the sample with an excess of a suitable matrix 
and the ionization of the analyte molecules by laser pulses. UV-MALDI instruments are usually endowed 
with nitrogen lasers emitting at 337 nm. The observed MALDI mass spectrum is a function of 
experimental variables which affect sensitivity and reproducibility: choice of matrix, physico-chemical 
properties of the analyte, matrix-analyte relative concentrations, method of spot preparation, laser 
characteristics and local environment [34, 35]. 
 
The currently proposed models of UV-MALDI action involve a two-step process: primary ionization, 
during or shortly after the laser pulse hits the matrix-analyte solid, followed by secondary ion-molecule 
reactions in the dense expanding plume of desorbed material. 
Two different models can be considered to explain primary ionization [36, 37]. 
 The cluster model. 
Analytes are incorporated in the matrix in a charged state defined by the solution pH. These 
"preformed" ions need to be separated from their counterions to generate free ions. The period 
during and soon after the laser pulse is characterized by high energy and material density, which 
causes the rapid generation and emission of clusters with an excess of positive or negative charge. 
Subsequent desolvation, either “soft” (loss of neutral matrix) or “hard” (ejection of charged 
matrix), frees the ions in the gas phase (Figure 1-18). 
 The photoexcitation/pooling model. 
This model proposes MALDI as the result of the combination of two processes: the migration of 
excitation energy in the matrix followed by pooling events, leading to matrix molecules with 
excitation states energetically sufficient for ionization. 
Secondary events take place in the expanding plume as soon as primary ions are formed. Analyte ions are 
derived from primary matrix ions by charge transfer reactions: 
 proton transfer: 
mH
+
 + A ↔ m + AH+   and   (m-H)- + A ↔ m + (A-H)- 
 electron transfer: 
m
+
 + A ↔ m + A+   and   m- + A ↔ m + A- 
 cation transfer (e.g.: mNa+ + A ↔ m + ANa+). 
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Figure 1-18. Scheme of the MALDI process. The cluster model of ion formation is 
represented in the upper box. m = matrix; A = analyte; R = generic counterion. Modified from 
Knochenmuss [37]. 
 
 
The roles of the matrix in MALDI are mainly two: it serves as a “solvent” for the analyte and it converts 
the photon energy absorbed from the laser beam into the excitation energy of the solid system. Therefore, 
the fundamental requirements that a matrix must meet can be summarized as follows: 
 solubility in solvents compatible with the analyte 
 ability to embed the analyte 
 lack of chemical reactivity 
 vacuum stability 
 absorbance at the chosen laser wavelength 
 molecular mass low enough to undergo sublimation 
 ability to promote analyte ionization. 
The selection of a suitable matrix depends on both the laser wavelength and the type of analyte. Common 
matrices used for UV-MALDI analyses of proteins and peptides are reported in Table 1-2. 
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Table 1-2. Common matrices used for UV-MALDI analyses of proteins and peptides.
 
 
The quality of the spectra strongly depends on sample preparation, although a good preparation for a 
given sample is to be determined empirically [38, 39]. 
The most common sample preparation techniques include: 
 Dried-droplet. This is the original method for sample preparation and still the most widely used. 
A volume of saturated solution of matrix is mixed 1:1 with the sample solution, typically in a 
molar ratio of 1:1000 to 1:10000. The mixture is spotted on the MALDI target and allowed to 
dry. This method well tolerates the presence of salts and buffers. 
A variation of the classical dried-droplet method is the vacuum-drying crystallization method, in 
which the drop of mixed matrix and analyte solutions is rapidly dried in a vacuum chamber, 
giving rise to small-sized crystals with an increased sample homogeneity, thus offering 
improvements in mass accuracy and resolution. 
 Slow crystallization. This method can be useful when samples contain non-volatile solvents or 
additives (e.g. glycerol, urea, DMSO), high salt concentrations, low protein concentrations. A few 
microliters of sample solution are mixed in a vial with about a tenfold volume of saturated matrix 
solution. The vial is left open in the dark for at least one hour to allow the formation of 
microcrystals. Then the supernatant is removed and the microcrystals are washed twice with cold 
aqueous solution. Finally, 1 µl of water is added to make a slurry of crystals which is applied on 
the sample plate and allowed to dry. 
 Fast-evaporation. A drop of the matrix solution, prepared in a highly volatile solvent, is applied 
on the sample plate. The solvent is allowed to evaporate, leaving a thin homogeneous film of 
small crystals of matrix. Then a drop of the analyte solution is applied and allowed to dry. This 
method can improve the resolution and mass accuracy of MALDI measurements. 
 Overlayer. The fast-evaporation method is exploited for the deposition of the first layer of small 
matrix-only crystals. A mixture of matrix and analyte solution is deposited on top of the first 
layer. This method offers good results particularly for proteins and mixtures of proteins or 
peptides. 
 Sandwich (combination of fast-evaporation and overlayer methods). The first matrix layer is 
deposited on the sample spot in the fast-evaporation method. The application of a sample droplet 
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on top of it is followed by the deposition of a second layer of matrix, this time solubilized in a 
traditional solvent. 
 Quick and dirty. A drop of analyte solution (0.1 – 10 mM) is spotted onto the sample plate, then 
a drop of matrix solution is added on top of it and the solutions are mixed thoroughly with a 
pipette before letting the mixture dry under an air or nitrogen steam. 
 Matrix-precoated target. This method is fast since it consists in the straightforward addiction of 
a droplet of sample on a thin layer matrix-pre-coated plate. 
 
Compared to other ionization techniques, MALDI is more tolerant to low concentrations of common 
contaminating species such as buffers, salts and detergents, that strongly interfere with the analyte 
desorption and ionization. However, when the concentration of contaminants is suspected to be high, a 
prior purification step is recommended. 
The main drawbacks of the MALDI technique are the strong dependence on the sample preparation, the 
low shot-to-shot reproducibility and also a short sample lifetime. 
 
ESI 
Mainly developed by Fenn and co-workers and described in 1989, ESI is an ion source that works at 
atmospheric pressure. Unlike MALDI, in which the analyte ions are produced in a pulsed way from a 
solid sample, ions in ESI are produced continuously from a liquid-phase sample. 
 
Ionization involves three major steps: droplet formation, droplet shrinkage and desorption of gas-phase 
ions (Figure 1-19) [34, 35]. 
o Droplet formation. The sample solution flows continuously through a stainless steel capillary 
tube whose tip is held at a high potential with respect to the walls of the surrounding atmospheric-
pressure region. In the positive-ion mode of operation, the difference of potentials between the tip 
(positive voltage) and the nozzle (the counter-electrode placed at negative voltage) generates an 
electrostatic field that causes cations to migrate towards the counter-electrode. This tendency to 
migrate is counterbalanced by the surface tension of the solution, giving rise to the Taylor cone at 
the tip of the capillary. If the applied electric field is strong enough, the flux of solution extending 
from the cone breaks into a mist of fine droplets. 
o Droplet shrinkage. Solvent evaporation, assisted by a flow of hot nitrogen, leads to droplet 
shrinkage and thus to the progressive increase of the charge density until the Rayleigh limit is 
reached. At this point, the repulsive coulombic forces exceed the droplet surface tension causing 
fission of the droplets into smaller and highly charged offspring droplets which in turn give rise 
to second-generation droplets. 
o Desorption of gas-phase ions. Two mechanisms have been proposed to explain ion desorption 
from the droplets: the charge-residue model (CRM) and the ion-desorption model (IDM) [40, 41]. 
Briefly, according to the charge-residue model, the electrospray process generates droplets that 
contain only one solute molecule which is released as an ion when the solvent evaporates. 
According to the ion-desorption model, expulsion of the solvated ions into the gas phase happens 
when the droplets reach a small size (about 20 nm of diameter) and the charge density is high, 
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although less than the Rayleigh limit. Because of coulombic repulsion, the energy gain in the 
electric field at the surface of the droplet compensates for the energy required to enlarge the 
surface of the droplet very rapidly when the solvated ion is expelled. 
It is generally believed that the ESI response depends on the nature of the analyte and in 
particular the ion-desorption model best applies to ions with significant surface activity whereas 
the charge-residue model applies largely to hydrophilic species. 
 
The characteristic multiple charging of ions in ESI occurs via charge distribution from the surface of the 
final droplet to the available charge-retaining sites on the solute molecule. 
 
 
Figure 1-19. Scheme of the ESI process. The proposed mechanisms of formation of gas-phase ions are 
represented in the upper box: the charge-residue model (A) and the ion desorption model (B). Modified from 
Dass [34] and Westman-Brinkmalm et al. [42]. 
 
Radio frequency (rf), multipoles (quadrupoles, hexapoles, octapoles) or “ion funnels” are commonly 
placed between the ESI source and the mass analyser to improve ion transmission efficiency. 
An additional source of energy, such as heat or a high-velocity annular flow of gas, is required when 
operating at high flow rates (0.2 to 1 ml/min) to disperse the liquid into fine droplets. 
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MASS ANALYZERS 
All mass analyzers use static or dynamic electric and magnetic fields, alone or combined, to measure the 
m/z ratio of gas-phase ions. 
Analyzers can be divided into two groups: 
 beam analyzers: ions leave the source in a beam and pass through the analyzer to the detector; 
 trapping analyzers: ions are trapped in the analyzer after being injected from the ion source or 
being formed in the analyzer itself. 
Since there are different types of sources, a variety of mass analyzers has been developed. Their main 
features are reported in Table 1-3. 
 
Table 1-3. Mass analyzers and their main features. 
ANALYZER Principle of separation Pulsed / continuous Resolution 
Quadrupole 
(Q) 
m/z 
(trajectory stability) 
Continuous Low 
Time-of-flight 
(TOF) 
velocity 
(flight time) 
Pulsed High 
Linear ion trap 
(LIT) 
m/z 
(resonance frequency) 
Pulsed Low 
Orbitrap 
(OT) 
m/z 
(resonance frequency) 
Pulsed Very high 
Fourier-transform 
ion cyclotron resonance 
(FT-ICR) 
m/z 
(resonance frequency) 
Pulsed Very high 
 
The main characteristics to be considered when evaluating the performances of a mass analyzer are: 
 mass range: the range of m/z values over which the analyzer can measure ions. It is expressed in 
Th or in u for an ion carrying an elementary charge (z = 1). 
 detection sensitivity: the smallest amount of an analyte that can be detected at a certain defined 
confidence level 
 mass resolution (resolving power): the ability to distinguish between two ions of close masses. If 
M is the mass of an ion and ΔM the difference between the two ion masses, the mass resolution is 
defined as the ratio M/ΔM. 
 mass accuracy: index of how close the experimentally measured mass (Mexp) is to the theoretical 
mass (Mth). It is usually expressed in parts-per-million: ppm = [(Mth – Mexp) / Mexp] ∙ 10
6
. Mass 
accuracy is directly linked to the resolving power. 
 transmission: the ratio between the number of ions reaching the detector and the number of ions 
entering the mass analyzer. 
 analysis speed (scan speed): the number of spectra acquired per unit of time. It is expressed in 
mass units per second (u s
-1
) or millisecond (u ms
-1
). Fast scan speed is desirable when 
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investigating rapidly changing events while slow scan speed is required in accurate mass 
measurement experiments. 
It is worth keeping in mind that sensitivity, resolution, accuracy and scan speed are in some ways linked 
together. 
 
The mass analyzers that were exploited in this work of thesis and their main applications are briefly 
described hereinafter. 
 
Time-of-flight (TOF) 
The time-of-flight analyzer consists of a field-free flight tube through which ions are separated on the 
basis of their velocities. The velocities of ions are an inverse function of the square root of their mass over 
charge values: 
 
The lower the m/z ratio of an ion, the faster the ion moves through the flight tube and reaches the 
detector. The time of flight of an ion, before reaching the detector, can be defined as: 
 
The measured arrival times of all ions provide a time spectrum that is converted into a mass spectrum by 
calibrating the instrument. 
Linear or reflector mode 
Ions are accelerated out of the source region with inherent dispersion in time, space and velocity, 
reflecting the differences in the instant of ion formation, the location of the ion at the time of acceleration 
and the differences in initial kinetic energy. 
Desorbed ions have inherent different initial velocities (v0). Therefore, after a period of time, ions of the 
same m/z will have a spread in space (condition 1 in Figure 1-20). Operating in linear mode, the spread of 
velocity increases till the ions reach the detector (situation 2 in Figure 1-20), leading to peak broadening. 
Improvement in resolution is possible operating in reflector mode. A reflectron is an energy-correcting 
device that minimizes the effects of spatial and kinetic energy spreads. It consists of grids and a series of 
ring electrodes, each with a progressively increasing repelling potential, commonly referred to as mirror. 
The mirror is placed at the end of the flight tube. Ions entering the mirror are slowed down (event 3 in  
Figure 1-20. and those with higher initial velocity will cover a longer distance before coming to rest: the 
shorter flight time is compensated by the extra time spent in the mirror. As a consequence, after reversing 
direction and after being reaccelerated into a second field-free region (situation 4 in Figure 1-20), ions 
with the same m/z ratio get to the detector simultaneously (point 5 in Figure 1-20) [42]. 
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Figure 1-20. Scheme of the ion path in a TOF analyzer. From Westman-Brinkmalm et al. [42]. 
 
Time-of-flight analyzers have a number of attractive features: the potential of an unlimited mass range, 
high ion-transmission efficiency, high spectrum-acquisition rate, multiplex detection capability, 
simplicity in instrument design, ease of use and low cost [43, 44]. 
4800 MALDI-TOF/TOF (AB SCIEX) 
The 4800 MALDI-TOF/TOF instrument and its main components are shown in Figure 1-21. 
 
 
 
Figure 1-21. 4800 MALDI TOF/TOF instrument (AB SCIEX) and a schematic representation of its main 
components. 
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The 4800 MALDI TOF/TOF mass spectrometer allows fast, sensitive, high resolution and accurate MS 
analyses of biomolecules, including peptides, intact proteins, lipids, carbohydrates and oligonucleotides. 
The system can also perform MS/MS analyses for precise identification and characterization of these 
biomolecules. 
The main components of the 4800 MALDI TOF-TOF mass spectrometer are: 
o source region with on-axis UV-laser, which increases sensitivity in both MS and MS/MS modes 
o TOF 
o linear detector 
o mirror region and reflector detector 
o QuanTIS (Timed Ion Selector) Precursor Selector, CID cell and source 2 region for high-
resolution MS/MS analyses. 
Peptide mass fingerprinting (PMF) 
MALDI-TOF-based peptide mass fingerprinting is a technique for protein identification. The process can 
be summarized as follows: 
a) isolation of single proteins from complex mixtures by bi-dimensional electrophoresis (2-DE) or 
liquid chromatography; 
b) digestion of the protein with a specific protease, usually trypsin; 
c) acquisition of the MALDI-TOF spectrum which represents the “fingerprint” of the protein; 
d) database search: identification of the unknown protein through the match of the experimental data 
with the theoretical peptide map of a protein present in the database. The identification is given with 
a score that greatly depends on sequence coverage and mass accuracy of the considered peptides 
[45]. 
Quadrupole (Q) 
Quadrupole analyzers are composed of four parallel circular metallic rods (electrodes), arranged in a 
squared array. Separation of ions of different m/z values is accomplished through the principle of path 
stability in a high-frequency oscillating electric field, created by applying direct-current (DC) and radio-
frequency (RF) potentials to those rods (Figure 1-22). 
 
Figure 1-22. Scheme of a quadrupole analyzer. From Rubakhin et al. [46]. 
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The field within the quadrupole is created by connecting electrically the opposite pairs of electrodes: one 
pair receives a superimposed positive DC potential (U) and a time-dependent RF potential (V·cosωt, 
where ω is the angular frequency of the applied RF voltage, V its amplitude and t the time), while the 
other pair of rods receives a negative DC potential (–U) and a RF potential of the same magnitude but out 
of phase by 180° (id est –U – Vcosωt). 
Different experiments can be performed: 
 if the DC is set to zero and only RF is applied, every ion trajectory is stable and all ions pass 
through the quadrupole. 
 when a set of defined DC and RF potentials are applied, only the ions with a specific m/z ratio have 
stable trajectories and pass through the quadrupole. The duty cycle (i.e. the percentage of time in 
which a particular ion is getting through the quadrupole and reaching the detector) is very high. 
 in the scanning mode, DC and RF potentials are varied simultaneously while keeping their ratio 
constant, allowing the ions with different m/z ratio to pass sequentially. In this instance, the duty 
cycle is low. 
The main characteristics of a quadrupole mass filter are: high scan speeds, high transmission, sensitivity, 
unit mass resolution, independence on the initial energy distribution of ions, linear mass range and also 
low cost and mechanical simplicity [43, 44]. 
 
Quadrupole ion trap (QIT) 
The quadrupole ion trap, also known as 3D ion trap, is the three-dimensional analogue of a quadrupole 
mass filter. Mass separation is achieved by storing the ions in the trapping space and by analyzing their 
motion in time, rather than in space. 
The three-electrode structure of a QIT consists of a central ring electrode and two identical end-cap 
electrodes, each with a hyperbolic geometry (Figure 1-23). One of the end-cap electrodes has a small 
aperture through which an electron beam can be gated periodically into the trapping space. The opposite 
end-cap electrode has several openings for the ejection of ions towards the detector. 
 
 
Figure 1-23. Scheme of a QIT analyzer. 
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The three-dimensional ion trapping field is created by applying a potential to the ring electrode and 
maintaining the end-cap electrodes at ground potential. Helium is introduced into the trap to cool the ions 
(reduction of the kinetic energy caused by collisions) and to focus them in the center of the trap. 
The mass spectrum of the trapped ions is acquired using the mass-selective instability mode of analysis, 
also known as mass-selective axial ejection. Increasing the magnitudes of the DC and RF voltages and the 
frequency of the RF signal, either singly or in combination, forces ions of successively increasing m/z 
values to become sequentially unstable in the axial direction and thus be ejected out of the trap. 
QIT mass analyzers have high scan speed and sensitivity and are compact, simple to operate and 
relatively low cost. On the other hand, their major drawbacks are poor resolution (unit), low dynamic 
range, poor ion-trapping efficiency [43, 44]. 
 
Quadrupole linear ion trap (LIT or LTQ) 
A quadrupole linear ion trap, also known as two-dimensional ion trap, is identical in construction to the 
quadrupole analyzer, although its operational modes are similar to those of the quadrupole ion trap. 
A LIT consists of two pairs of hyperbolic rods, connected electrically. The four parallel rods are 
segmented into three axial sections, with the central section about three times longer than the two end 
sections (Figure 1-24). Mass analysis of the trapped ions is performed by using the mass-selective 
instability mode with radial ejection of the trapped ions through the slit present along the length of one of 
the rods of the central section. 
 
 
Figure 1-24. Scheme of a LIT analyser. 
 
In comparison with a 3D ion trap, a LIT shows improved trapping efficiency, ion storage capacity, ion-
ejection efficiency, scan speed and detection sensitivity [43, 44]. 
4000 TRAP (AB SCIEX) 
The 4000 Q TRAP instrument and its main components are shown in Figure 1-25 and Figure 1-26. 
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Figure 1-25. The 4000 and 5500 QTRAP LC/MS/MS Systems (AB SCIEX). 
 
 
Figure 1-26. Scheme of the main components of the 4000 QTRAP mass spectrometer. 
 
The main components of the 4000 QTRAP mass spectrometer are: 
o Q0. High-pressure cell that performs collisional focusing to maximize the transmission of ions. 
Furthermore, in MS/MS or MS
3
 experiments, ions can be trapped in Q0 while the Q3 is scanning 
ions, thus improving sensitivity and duty cycle. 
o Q1. 
o Q2 with LINAC Collision Cell. The LINAC high-pressure collision cell accelerates ions through 
the Q2 providing great sensitivity at reduced dwell times. 
o Q3 Linear Ion Trap. 
Q TRAP modes of operation 
The Q TRAP mass spectrometer can be operated either in QqQ or LIT modes [47]. 
QqQ modes: 
 Q1 MS (Q1). A full scan using the first quadrupole (Q1) as the mass filter for specific masses. The 
ion intensity is returned for every requested mass in the scan range. Used for target compound 
analysis. 
 Q1 Multiple Ions (Q1 MI). A scan using the first quadrupole (Q1) as the mass filter. The ion intensity 
is returned for specific masses. 
 Q3 MS (Q3). A full scan using the third quadrupole (Q3) as the mass filter. The ion intensity is 
returned for every requested mass in the scan range. 
 Q3 Multiple Ions (Q3 MI). A scan using the third quadrupole (Q3) as the mass filter. The ion 
intensity is returned for specific masses. Used for target compound analysis. 
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 Product Ion (MS2). An MS/MS scan in which the first quadrupole is set to a fixed mass and the third 
quadrupole sweeps a mass range. An experiment that will search for all of the products of a particular 
precursor ion fragmenting in Q2. 
 Precursor Ion (Prec). An MS/MS scan in which the third quadrupole is set to a fixed mass and the 
first quadrupole sweeps a mass range. A scan for the ion of a specific mass-to-charge ratio that is 
generating specific product ions. 
 Neutral Loss (NL). An MS/MS scan in which both the first quadrupole and the third quadrupole are 
swept over a mass range using a fixed mass difference between them. A response will be observed if 
the ion chosen by the first analyzer fragments by losing or gaining the mass difference or neutral loss 
specified. 
 Multiple Reaction Monitoring (MRM). Mode of operating a triple quadrupole instrument so that an 
ion of a given mass (Q1) must fragment or dissociate to give a product ion of specific mass (Q3) in 
order for a response to be detected. Used for very specific target compound analysis. 
LIT modes for screening, confirmation and identification applications [47]: 
 Enhanced MS (EMS). An MS full scan in which all the ions in the specified m/z range are trapped in 
LIT for a specified fill time prior to being scanned out and detected. 
 Enhanced Multi-Charge (EMC). An MS scan in which multiply-charged ions are detected within the 
specified range. Singly-charged ions are of minimum intensity. 
 Enhanced Resolution (ER). An MS scan in which ions within a 20 Da region are collected in LIT for 
a specified fill time and scanned out slowly for enhanced resolution. The ER scan is useful to 
determine charge states and isotopic patterns. 
 Enhanced Product Ion (EPI). An MS/MS scan in which Q1 filters the parent ion that is fragmented in 
Q2. Fragment ions are trapped in LIT for a specified fill time prior to being scanned out. The EPI 
mode can be used to confirm the presence of the detected analyte by interpretation of fragment ions. 
 MS/MS/MS (MS3). A scan in which product ions generated in Q2 are collected in LIT. Product ions 
of a specified m/z are isolated in LIT and further fragmented. The resulting fragment ions are trapped 
into LIT prior to being scanned out and detected. 
MRM analyses of mixtures of peptides 
Multiple reaction monitoring (MRM) is a specific and sensitive method to quantify target proteins within 
complex mixtures. The MRM process consists of a series of steps (Errore. L'origine riferimento non è 
stata trovata.): 
1. ionization of the components of the digestion mixture; 
2. Q1: selection of the proteotypic peptide of known m/z (precursor ion). A proteotypic peptide is a 
peptide unique to the protein of interest. When possible, to maximize the sensitivity of the 
analysis, it is better to choose a peptide showing high signal response; 
3. Q2: fragmentation of the precursor ion with N2; 
4. Q3: selection of product ion with known m/z (transition). The term transition refers to the specific 
pair of m/z values associated to the precursor and fragment ions respectively; 
5. acquisition of a spectrum of signal intensity as function of time; 
6. quantitation of the protein of interest identified by the proteotypic peptide. 
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Figure 1-27. Scheme of a MRM analysis. 
 
Orbitrap (OT) 
The orbitrap analyzer is an electrostatic ion trap that exploits the Fourier transform to obtain mass spectra. 
The instrument is composed of an axial spindle-like central electrode and a coaxial barrel-like outer 
electrode, cut into two equal parts separated by a small slit. The outer electrode is at ground potential 
while an electrostatic potential is applied to the spindle-like electrode. Ions enter the orbitrap tangentially 
through the fissure between the two parts of the outer electrode. The trapped ions undergo rotation around 
the central electrode and harmonic oscillations along its length (Figure 1-28). The frequencies of the 
harmonic oscillations of the trapped ions, a function of their m/z values, are converted to mass spectra 
using fast FT [48, 49]. Characteristics of OT instruments are high accuracy and resolving power but 
relatively limited dynamic range [43, 44]. 
 
Figure 1-28. Scheme of an orbitrap analyzer. 
LTQ-Orbitrap XL (Thermo Scientific) 
LTQ-Orbitrap XL instrument and its main components are shown in Figure 1-29 and Figure 1-30. 
 
Figure 1-29. LTQ-Orbitrap XL mass spectrometer (Thermo Scientific). 
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Figure 1-30. Scheme of the main components of the LTQ-Orbitrap XL mass spectrometer. 
 
The characteristic components of the LTQ-Orbitrap XL mass spectrometer are: 
o LTQ XL Linear Ion Trap. The ion trap can store, select and fragment ions (CID) before sending 
them to the Orbitrap. The trap also features Automatic Gain Control (AGC), which provides 
extended dynamic range and ensures that the Orbitrap is always filled with the optimum number 
of ions for all scans. 
o Transfer octopole. 
o C-trap (a gas-filled, curved, RF-only quadrupole). In the C-trap ions are accumulated and their 
energy is dampened using a bath gas (nitrogen). Radial ejection from the C-trap is the most recent 
device for injection of ion packets with narrow spatial and temporal distributions into the 
Orbitrap analyzer. 
o HCD (Higher-energy Collision Dissociation) cell. 
The fragmentation process involves four major steps: 
1) precursor ion selection in the linear ion trap; 
2) ion fragmentation in the HCD collision cell; 
3) transfer of product ion back to the C-trap 
4) immediate ejection into the Orbitrap mass analyzer for accurate mass detection. 
o Orbitrap analyzer. 
 
Ion mobility spectrometer (IMS) 
Ion mobility mass spectrometers are hybrid instruments that combine an ion mobility separation system 
with conventional MS systems. An ion mobility spectrometer (IMS) can also serve as a stand-alone ion 
detection system. 
The operating principle of an IMS is based on the mobility of a gas-phase ion under both the positive 
influence of an electrical field gradient and a negative influence of a cross-flow of buffer gas. In these 
conditions, the mobility of an ion essentially depends on its mass, charge and collision cross section 
(shape): ion charges being equal, small and compact ions with small collision cross sections drift more 
quickly than large and extended ions with large collision cross sections (Figure 1-31). 
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Schematically, a typical ion mobility spectrometer consists of a reaction region and a drift region 
separated by an electrical shutter. Both regions contain a series of uniformly spaced electrodes that 
provide uniform electric field strength. Buffer gas is also circulated in the drift tube. Ion mobility is a 
property that results from the combined effect of ion acceleration by the electric field and retardation by 
collisions with the buffer gas. The resolution of an IMS is usually very low but can be increased by 
increasing the pressure of the buffer gas, connecting the ion source directly with the drift tube, increasing 
the length of the drift tube and increasing the electric field gradient of the drift tube [43, 44]. 
 
 
Figure 1-31. Scheme of an ion mobility mass spectrometer. Modified from Dass [43]. 
 
For more accurate mass analysis, an ion mobility spectrometer can be coupled with a quadrupole or TOF 
analyzer: the IMS serves as a separation device while the quadrupole or TOF operates as a detection 
device. 
Synapt G2-S (Waters) 
Synapt G2-S instrument and its main components are shown in Figure 1-32 and Figure 1-33. 
 
 
Figure 1-32. Synapt G2-S mass spectrometer (Waters). 
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Figure 1-33. Main components of Synapt G2-S. 
 
Characteristic features of the Synapt G2-S are: 
o StepWave region. 
Thanks to its particular design, the StepWave transfers the ions from the ion source to the 
quadrupole analyzer with high efficiency while eliminating neutral contaminants. Therefore it 
increases signal intensity and minimizes background noise. 
o TriWave region. 
It is essentially composed of three components: two TWIGs (Travelling Wave Ion Guides) with 
the ion mobility separation cell in between. 
 Trap T-Wave. This cell traps the ions prior to the ion mobility separation. 
 Ion Mobility Separation (IMS) T-Wave. This is the cell where separation of ions based on 
their mobility actually takes place. It is preceded by an helium cell that maximizes 
transmission of ions. 
 Transfer T-Wave. This cell transfers the ions coming from the IMS cell to the TOF 
analyzer. 
Both the Trap and Transfer T-Waves can be operated as collision cells. 
o QuanTOF analyzer. 
The user can choose between different modes of operation of the QuanTOF: 
- sensitivity mode (“V path”) 
- resolution mode (“V path”) 
- high resolution mode (“W path”). 
HDMS
E
 analysis 
High definition mass spectrometry (HDMS) is the combination of high resolution mass spectrometry and 
high efficiency ion mobility. In HDMS
E
 experiments the IMS cell provides an extra dimension of ion 
separation while the transfer collision cell cycles between low and high collision energy states so that the 
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precursor and its fragment ions alternatively pass through and are detected (Figure 1-34). HDMS
E
 collects 
exact mass data for both precursor and fragment ions. 
 
 
Figure 1-34. Scheme of High Definition MSE experiments (HDMSE) with Synapt G2-S. 
 
Analyses of complex mixtures and structural investigations of gas-phase ions are possible thanks to the 
ability of the instrument to differentiate chimeric molecules (increased peak capacity) in a wide dynamic 
range with high accuracy and resolving power. 
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TANDEM MASS SPECTROMETRY 
The term tandem mass spectrometry (also known as MS/MS) refers to the coupling of two or more mass 
spectrometers (tandem in-space) or stages of mass analysis (tandem in-time), with fragmentation 
occurring between them [50, 51]. 
Tandem in-space instruments. 
The three steps of a MS/MS analysis (i.e. mass selection, fragmentation and mass analysis) are carried out 
in three discrete regions. Examples of tandem in-space instruments are the triple quadrupoles and the 
TOF-based instruments. 
Tandem in-time instruments. 
Mass selection, fragmentation and mass analysis are performed in the same region but in a temporal 
sequence. Examples of tandem in-time instruments are the Quadrupole Ion Trap, the Linear Ion Trap and 
the Fourier-transform ion-cyclotron resonance mass spectrometers. 
 
The major contributions of tandem mass spectrometry are in the fields of: 
 structure elucidation of unknown compounds 
 identification of compounds in complex mixtures 
 elucidation of fragmentation pathways 
 quantification of selected compounds in complex samples. 
 
Tandem mass spectrometers allow to perform various types of experiments (Figure 1-35): 
A. Product ion scanning. 
The purpose of this experiment is the generation of a fragment ion spectrum from an analyte of 
interest. The first analyzer (MS1) is set to a value that selects one specific precursor ion at a time. 
The selected ion undergoes CID in the collision cell and the resulting fragments are then analyzed 
by the second analyzer (MS2). 
B. Precursor ion scanning. 
This method is typically used to detect a specific subset of peptides in a complex mixture. MS2 is 
set to transmit only one specific fragment ion to the detector while MS1 is scanned to detect all 
the precursor ions that generate this fragment. 
C. Neutral loss scanning. 
Neutral loss scanning allows the detection of peptides that contain a specific functional group. In 
this experiment both analyzers scan in a synchronized manner so that the mass difference of the 
ions passing through MS1 and MS2 remains constant. The mass difference corresponds to a 
neutral fragment that is lost by the precursor ion in the collision cell. 
D. Multiple ion monitoring. 
This experiment allows the detection and quantification of a target analyte, with known 
fragmentation properties, in complex samples. MS1 filters a specific precursor ion and MS2 
selects a specific fragment, characteristic for that precursor. Typically, the instrument cycles 
through a series of transitions (precursor-fragment pairs) and records the signal as a function of 
time, correspondent to the chromatographic elution. 
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Figure 1-35. Scheme of various types of tandem mass experiments. From Domon [52]. 
 
Peptide fragmentation 
The types of fragment ions observed in a MS/MS spectrum depend on many factors, including the 
primary sequence, the charge state, the amount of internal energy and how the energy was introduced. 
Only fragments carrying at least one charge can be detected. If this charge is retained on the N-terminal 
fragment, the ion is classified as either a, b or c, otherwise, if the charge is retained on the C-terminal 
fragment, the ion type is either x, y or z, all with a subscript number indicating the number of residues in 
the fragment ( 
Figure 1-36.). 
 
 
Figure 1-36. Nomenclature of the potential fragments of a precursor ion. 
 
In low energy CID (i.e. collision-induced dissociation) a peptide carrying a positive charge fragments 
mainly along its backbone, generating predominantly b and y ions. In addition, a*, b* and y* ions, with 
the star indicating loss of ammonia (-17 Da), are frequently observed when fragments contain R, K, N, or 
Q residues, while a°, b° and y° ions, with the ° indicating loss of water (-18 Da), are frequently observed 
when fragments contain S, T, E or D residues. 
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Early diagnosis of infection is of paramount importance in neonatology clinical care units since it has a 
major impact on therapy management, clinical course and patient outcome. The traditional methods for 
the diagnosis of sepsis (i.e. cultures of blood, urine, cerebrospinal fluid or bronchial fluid specimens) 
usually take 24 to 48 hours. Furthermore, clinical symptoms frequently manifest themselves in the 
absence of a positive culture [53-55]. In view of the above diagnostic and therapeutic dilemmas, a more 
unequivocal test for the differential diagnosis of infection and sepsis is needed. 
 
 
The main aim of the project was the investigation of saliva as a biological fluid reporting on health status 
of newborns followed by the development of an innovative and noninvasive diagnostic method to 
differentiate bacterial from noninfectious causes of inflammation. 
 
Two parallel approaches were applied. 
 
 Untargeted analysis to characterize the protein composition of whole saliva samples collected from 
healthy newborns within 48 hours after birth according to a precise study protocol approved by the 
local ethical committee. The comparison between healthy and unhealthy newborns will eventually 
highlight the alteration of whole saliva protein patterns as well as over or under-expressed proteins. 
 
 Targeted analysis of acute-phase proteins widely considered plasmatic markers of sepsis, C-
reactive protein, calcitonin and its precursor procalcitonin, to develop an analytical MS-based 
method to qualitatively and quantitatively assay them within salivary samples. 
 
The bioanalytical platform has been applied to saliva samples. However, the developed methods and 
strategies can be adapted to other biological fluids. 
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3.1. UNTARGETED GEL-BASED APPROACHES 
In this thesis, untargeted gel-based approaches were exploited to characterize the protein content of 
salivary samples collected from healthy newborns in their early 48 hours after birth. The comparison 
between healthy newborns and newborns affected by bacterial infection will be carried out at a later stage 
of the project. In particular the aims of this phase of the study were the description of the overall protein 
profile and the identification of the most abundant proteins, as well as the clarification of the differences, 
if present, occurring between samples collected in the first and in the second day of life. Both 2D-PAGE 
– MALDI-TOF/TOF and SDS-PAGE – LC-(HR)MS/MS analyses were performed in order to collect 
complementary information (Figure 3-1). 
Results are showed in this section and discussed in paragraph 4.1. 
 
 
Figure 3-1. Scheme of the gel-based discovery approaches applied in this work of 
thesis: 2D-PAGE and MALDI-TOF/TOF (A) and 1D-PAGE and LC-(HR)MS/MS (B). 
2-DE analyses were performed on both single samples and pooled samples. 
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2-DE – MALDI-TOF/TOF 
To begin with, some of the collected salivary samples were analyzed individually to explore the intra- and 
inter-individual variability. Later, analyses of pooled samples were performed for a more comprehensive 
examination of the protein content in healthy newborns. 
 
Single newborn analyses 
Three newborns were individually analyzed (Table 3-1). For each newborn the sample collected within 24 
hours after delivery (day 1) and the one collected between 24 and 48 hours after delivery (day 2) were 
analyzed separately and in duplicate, therefore four 2-DE gels were obtained for each newborn. 
 
Table 3-1. Clinical data of newborns whose samples were individually exploited to perform 2-DE 
analyses. 
 
 
Each gel was at first stained with Bio-safe Coomassie Blue and then, after destaining, a Silver staining 
was performed (Figure 3-2). 
 
 
Figure 3-2. Example images of the same 2-DE gel stained at first with Bio-safe Coomassie Blue (A) and later 
with Silver staining (B). The difference in sensitivity between the two stains can be appreciated. 
 
The images acquired after Coomassie and Silver staining were compared. As expected, the latter staining 
exhibited greater sensitivity (low ng): considering all the spots detected in the first and in the second day 
of the three newborns analyzed, an average of 105 spots were detected with Coomassie staining versus an 
average of 305 spots detected with the Silver staining. Therefore, almost the 65% of the total number of 
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spots detected are present in amounts included between the limits of detection of the two stains (0.5-10 
ng). 
 
The MALDI-TOF analysis of the digestion solutions of the excised spots led to define the identity of the 
most abundant proteins in the oral fluid samples: polymeric immunoglobulin receptor (PIGR), serum 
albumin, keratins and actins (Figure 3-3). 
 
 
Figure 3-3. Image of a 2-DE gel showing the regions were most abundant proteins 
focalize: polymeric immunoglobulin receptor (PIGR), serum albumin, keratins and 
actins focalize in the gel regions marked in green, yellow, pink and blue respectively. 
 
Pool analyses 
Two distinct pools were created, merging respectively the extraction solutions of samples collected from 
six healthy newborns within 24 hours after delivery (day 1) and between 24 and 48 hours after delivery 
(day 2) (Table 3-2). Pools were created using the same amount of protein from each sample and a total 
protein quantity of 40 µg was loaded onto each IPG strip. 
 
Table 3-2. Clinical data of newborns whose samples were pooled to perform 2-DE analyses of day 1 
and day 2. 
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The pool were analyzed separately and in duplicate, therefore four 2-DE gels were obtained (Figure 3-4). 
 
 
Figure 3-4. Images of the gels obtained from the 2-DE analysis of the pool (silver staining): 
A) and B) are technical replicates of the pool obtained from 6 samples collected from newborns 
within 24 hours after delivery (day 1), whereas C) and D) are technical replicates of the pool 
obtained from 6 samples collected from the same newborns between 24 and 48 hours after 
delivery (day 2). 
 
3. Results 
 
50 
 
Image analysis of the four gels was performed with PDQuest software (Figure 3-5). Gel C) in Figure 3-4 
was taken as reference. 
 
 
 
 
Figure 3-5. Image analysis of the pool. The upper schematic shows the relationship between the 
number of spots detected in each of the four gels and the number of spots matched with the gel taken 
as reference (gel C). The bottom schematic shows the match rate 1 value for each gel. A and B are 
technical replicates of day 1, whereas C and D are technical replicates of day 2. 
 
 
 
Gel B and D, second technical replicate of day 1 and 2 respectively, were compared and a scatter plot was 
obtained, highlighting the matched spots whose intensity varied more than twofold up or down (Figure 
3-6). Among the matched spots, protein S100-A8 (calgranulin-A), protein S100-A9 (calgranulin-B) and 
Heat shock protein beta-1 (Hsp27) were identified as proteins whose intensity in day 1 was more than 
twofold higher than in day 2. 
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Figure 3-6. Comparison between day 1 and day 2. Scatter plot: x-axis = gel B and y-axis = gel D. 
 
The identification of Hsp27 is reported as an example (Figure 3-7 and Figure 3-8). 
 
 
Figure 3-7. List of potential identifications from the analysis of the MALDI-TOF spectrum acquired. 
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Figure 3-8. Detail of the identification of Heat-shock protein beta-1. The upper table reports the amino acidic 
sequence of the identified peptides with the match errors between the observed and the calculated mass values. The 
table also reports for each peptide its position in the protein and the fixed/variable modifications (if present). 
 
 
 
Another pool was analyzed merging the extraction solutions of samples collected from four healthy 
newborns on their second day after birth (Table 3-3). 
 
Table 3-3. Clinical data of newborns whose samples were pooled to perform a 2-DE analysis of day 2. 
 
 
Once again, the pool was created using the same amount of protein from each sample, but this time a total 
protein quantity of 100 µg was loaded onto the IPG strip and the 2-DE gel obtained was stained with 
Coomassie blue (Figure 3-9). 
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Figure 3-9. Coomassie staining of the 2-DE gel of the pool obtained from 
samples collected from four newborns on their second day after birth. 
 
 
 
 
Overall, the identifications obtained from the MALDI-TOF analysis of digested protein spots are reported 
in Table 3-4. 
 
 
Table 3-4. List of identifications obtained from the 2-DE – MALDI-TOF/TOF 
analyses of pooled samples. The identified proteins are reported in alphabetical order. 
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The main features of the identified proteins are summarized in the following charts (Figure 3-10 and 
Figure 3-11). 
 
 
Figure 3-10. Pie charts summarizing the main characteristics of the identified proteins: molecular weight (A) 
and isoelectric point (B). 
 
 
Figure 3-11. Pie chart summarizing the location of the identified proteins. 
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SDS-PAGE – LC-(HR)MS/MS 
An experiment of mono-dimensional SDS-PAGE followed by band excision, tryptic digestion and LC-
(HR)MS/MS analysis was performed to evaluate the feasibility of the method and its complementarity 
compared to the designed 2-DE – MALDI-TOF/TOF approach (Figure 3-12). 
 
 
Figure 3-12. Image of a mono-dimensional SDS-PAGE gel. The sample was loaded in duplicate. 
 
Identifications were obtained and a list is reported in Table 3-5. The main features of the identified 
proteins are summarized in the following charts (Figure 3-13 and Figure 3-14). 
 
 
Figure 3-13. Pie charts summarizing the main characteristics of the identified proteins: molecular weight (A) 
and isoelectric point (B). 
 
 
Figure 3-14. Pie chart summarizing the location of the identified proteins. 
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Table 3-5. List of identifications obtained from the SDS-PAGE – LC-(HR)MS/MS analysis of a single-
newborn sample. The identified proteins are reported in decreasing order of molecular weight. 
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3.2. TARGETED ANALYSES 
While waiting for the identification of a specific target protein (or a pattern of target proteins) through the 
gel-based discovery approach, the targeted analysis was focused on the development of an analytical 
method based on liquid chromatography coupled to mass spectrometry to qualitatively and quantitatively 
assay C-reactive protein, calcitonin and its precursor procalcitonin, acute-phase proteins widely 
considered plasmatic markers of sepsis. 
In the following sections the results of the mass spectrometric characterization of hCT, hPCT and hCRP, 
are reported. The development of the most appropriate sample preparation conditions in order to 
accurately assay the above-mentioned proteins within biological samples is shown together with the 
progressive optimization of the chromatographic and mass spectrometric conditions used with the 
different analytical platforms. The general workflow of analysis is summarized in Figure 3-15. 
 
Figure 3-15. General workflow of analysis of human calcitonin, human procalcitonin and C-reactive protein 
applied in this thesis. The main variables explored in the aqueous or organic-aqueous digestion step are reported. 
The following MS analyses of the digestion solutions were carried out exploiting three different instruments (4800 
MALDI-TOF/TOF, 4000 Q TRAP and Synapt G2-S) to gather complementary information on the proteins of 
interest. 
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MALDI-TOF-based peptide mass fingerprinting was exploited to compare different sample preparation 
conditions and in particular to test the feasibility of a mixed organic-aqueous digestion instead of a 
classical procedure in aqueous solution. MALDI-TOF/TOF spectra were also acquired in some cases to 
identify peptides whose signal was not expected on the basis of a theoretical tryptic cleavage, due to the 
presence of missed cleavages. 
Q TRAP infusion analyses were performed to verify the ESI ionizability of the peptides of interest as 
multiply charged species and to figure out the optimal experimental conditions for the fragmentation of 
the proteotypic peptides, especially in the triple quadrupole mode, with a view to the subsequent MRM 
analyses. 
Whenever possible, MS
E
 experiments were carried out to evaluate the applicability of a similar platform 
to high-throughput screening of the proteins of interest and their post-translational modifications within 
biological samples. 
Results are showed in this section and discussed in paragraph 4.2. 
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TARGETED ANALYSES IN AQUEOUS SOLUTION 
Human calcitonin 
Analysis of the intact protein 
Solubilization of the human calcitonin (hCT) standard at 1 mg/ml was performed in 20 mM ammonium 
bicarbonate. MALDI-TOF analysis was performed in order to characterize the standard solution prior to 
the tests of different sample preparations (Figure 3-16). 
 
Figure 3-16. MALDI-TOF spectrum of human calcitonin standard. 
 
Sequence 
Length 
(aa) 
Theoretical 
monoisotopic 
molecular weight 
Experimental 
monoisotopic 
[M+H]
+
 
CGNLSTCMLGTYTQDFNKFHTFPQTAIGVGAP 32 3418.58 3416.6716 
 
The theoretical monoisotopic molecular weight reported in the upper table was calculated on the basis of 
the amino acidic sequence, but because of the disulfide bond between cysteine 1 and 7 and the amidated 
C-terminal proline, the effective theoretical monoisotopic molecular weight of intact human calcitonin is 
3415.5789 Da. Therefore, the experimental monoisotopic weight observed is in good agreement with the 
expected one. 
 
Two different protein denaturation procedures were considered: a SDS-based denaturation and a 
urea/thiourea procedure. 
SDS-based denaturation 
Two different sample preparations were tested, one at 4 °C and the other at 37 °C. 
Protocol 1: 
- thawing of an aliquot of frozen hCT stock solution (1 mg/ml in 20 mM ammonium bicarbonate) 
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- denaturation and reduction in 0.1% SDS, 48 mM DTE; 5 minutes at 95 °C, then 1 hour at 4 °C 
- alkylation in 100 mM IAA, 30 minutes at 4 °C in the dark 
- sample desalting with GE Healthcare PD Mini-Trap G-10 
- protein concentration in speed-vac to theoretical concentration of 0.1 mg/ml. 
Protocol 2: 
- thawing of an aliquot of frozen hCT stock solution (1 mg/ml in 20 mM ammonium bicarbonate) 
- denaturation and reduction in 0.1% SDS, 48 mM DTT; 5 minutes at 95 °C, then 1 hour at 37 °C 
- alkylation in 100 mM IAA, 30 minutes at 37 °C in the dark 
- desalting with GE Healthcare PD Mini-Trap G-10 → elution at theoretical protein concentration of 
48 µg/ml. 
Neither of the two preparations gave satisfactory results in terms of yield of the alkylation reaction (data 
not shown). 
 
Protein denaturation in urea and thiourea mixture 
Sample preparation: 
- protein denaturation in 20 mM ammonium bicarbonate, 6 M urea, 2 M thiourea 
- reduction in 48.75 mM DTT, 30 minutes at 25 °C 
- alkylation in 100 mM IAA, 30 minutes at 25 °C in the dark 
- desalting with GE Healthcare PD Mini-Trap G-10. 
MALDI-TOF ANALYSIS 
The MALDI-TOF spectrum acquired shows that the reduction of the disulfide bond and the subsequent 
alkylation of the cysteine residues can be considered complete: most of the protein is in the bis-alkylated 
state and only a small fraction is in the mono-alkylated state (Figure 3-17). 
 
 
Figure 3-17. MALDI-TOF spectrum of intact hCT after the alkylation reaction. 
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Peptide 
Length 
(aa) 
Position 
Theoretical 
monoisotopic 
molecular weight 
Experimental 
monoisotopic 
[M+H]
+
 
Human calcitonin 32 1 – 32 3418.58 - 
Mono-alkylated human calcitonin 32 1 – 32 3475.60 3475.6731 
Bis-alkylated human calcitonin 32 1 – 32 3532.62 3532.6697 
 
Q TRAP INFUSION ANALYSIS 
The solution of intact hCT was infused in the Q TRAP and analyzed in EMS mode (Figure 3-18). 
 
 
Figure 3-18. EMS spectrum of intact hCT after the alkylation reaction. 
 
The m/z value of the most abundant ion in the full scan spectrum was compatible with the one expected 
for the triply-charged ion of the bis-alkylated intact protein. Therefore an ER spectrum was acquired, 
which confirmed the triply-charge state of the ion of interest (Figure 3-19). 
 
 
Figure 3-19. ER spectra of m/z 1179.0 (A) and 1768.0 (B), the triply- and doubly-charged ions of the bis-
alkylated intact hCT respectively. 
 
Intact hCT with alkylated Cys residues mainly ionizes in ESI as [M+3H]
3+
 (m/z 1179.0). 
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EPI and MS2 fragmentation spectra were acquired for the triply-charged ion of the bis-alkylated intact 
protein (Figure 3-20 and Figure 3-21 respectively). 
 
 
Figure 3-20. EPI spectrum of the triply-charged ion of the bis-alkylated intact hCT (m/z 
1179.0). Applied CE = 40. The precursor ion is marked in red. 
 
 
 
Figure 3-21. MS2 spectra of the triply-charged ion of the bis-alkylated intact hCT (m/z 1179.0). 
The applied CE values are 40 (A) and 50 (B) volts. The precursor ion is marked in red. 
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MRM ANALYSIS 
The following transitions were analyzed: 
 
m/z 
precursor ion 
(Q1) 
m/z 
fragment ion 
(Q3) 
Fragment ion 
1179.0 1711.0 y32(2+) 
1179.0 1569.0 y15(1+) 
1179.0 1141.0 y32(3+) 
1179.0 1249.0 y23(2+) 
1179.0 910.0 y10(1+) 
 
Linearity in the theoretical range of concentrations 0.4 – 50 µg/ml was tested and calibration curves were 
obtained (Figure 3-22). 
 
 
Figure 3-22. Calibration curves obtained for intact hCT. 
 
R
2
 values are ≥ 0.983 for each of the transitions analyzed. 
 
 
Analysis of the digested protein 
The peptides originated by a virtual tryptic digestion of hCT are reported in Table 3-6, together with their 
cleavage probabilities. 
 
Table 3-6. Tryptic digestion of hCT: cleavage sites and cleavage probabilities. From 
http://web.expasy.org/peptide_cutter/ 
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Two protocols of digestion in aqueous solution were tested for hCT, essentially differing in the 
denaturing step: the first protocol was based on SDS and thermal denaturation whereas the second 
protocol was based on urea and thiourea mixture. 
 
Protein denaturation in SDS 
Protocol based on SDS and thermal denaturation: 
- denaturation and reduction in 100 mM NH4HCO3, 0.1% SDS, 9.5 mM TCEP, 5 minutes at 95 °C 
- alkylation in 17 mM IAA, 30 minutes at 25 °C in the dark 
- sample dilution 2x in 100 mM ammonium bicarbonate 
- in-solution digestion: 16 hours at 37 °C with trypsin 1:25 (w/w) 
- quenching of digestion by addition of 0.1% formic acid. 
MALDI-TOF ANALYSIS 
Desalting of the digestion solution of hCT prior to MALDI-TOF analysis was performed using a ZipTip 
C18 Pipette Tip. The MALDI-TOF spectrum of the digestion solution is characterized by the presence of 
signals which can be attributed to hCT peptides, although a large part of the protein remained intact 
(Figure 3-23). 
 
 
Figure 3-23. MALDI-TOF spectrum of the digestion solution of hCT. 
 
Peptide sequence 
Length 
(aa) 
Position 
Theoretical 
monoisotopic 
molecular weight 
Experimental 
monoisotopic 
[M+H]
+
 
FHTFPQTAIGVGAP 14 19 – 32 1441.74 1441.7343 
C[alk]GNLSTC[alk]MLGTYTQDFNK 18 1 – 18 2108.89 2109.9146 
Bis-alkylated human calcitonin 32 1 – 32 3532.62 3532.8342 
Sequence coverage = 100% 
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Protein denaturation in urea and thiourea mixture 
Protein denaturation using urea and thiourea: 
- denaturation in 20 mM NH4HCO3, 6 M urea, 2 M thiourea 
- reduction in 48.75 mM DTT, 30 minutes at 25 °C 
- alkylation in 100 mM IAA, 30 minutes at 25 °C in the dark 
- desalting with GE Healthcare PD Mini-Trap G-10 
- in-solution digestion: 15 hours at 37 °C with trypsin 1:50 (w/w) 
- quenching of digestion by addition of 0.1% formic acid. 
 
MALDI-TOF ANALYSIS 
 
The MALDI-TOF spectrum of the digestion solution is characterized by the presence of signals which 
can be attributed to the two expected hCT peptides (Figure 3-24). 
 
 
Figure 3-24. MALDI-TOF spectrum of the digestion solution of hCT. 
 
Peptide 
Length 
(aa) 
Position 
Theoretical 
monoisotopic 
molecular weight 
Experimental 
monoisotopic 
[M+H]
+
 
FHTFPQTAIGVGAP 14 19 – 32 1441.74 1441.7620 
C[alk]GNLSTC[alk]MLGTYTQDFNK 18 1 – 18 2108.89 2109.9146 
Bis-alkylated human calcitonin 32 1 – 32 3532.62 3532.6548 
Sequence coverage = 100% 
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QTRAP INFUSION ANALYSIS 
 
The digestion solution of hCT was infused in the Q TRAP and analyzed in EMS and Q1 full scan modes 
(Figure 3-25). 
 
 
Figure 3-25. Comparison between the EMS spectrum (A) and the Q1 spectrum (B) of hCT digestion 
solution. 
 
Tryptic digestion of hCT produces two peptides that mainly ionize in ESI as [M+2H]
2+
: 
 N-terminal peptide C[alk]GNLSTC[alk]MLGTYTQDFNK 
 C-terminal peptide FHTFPQTAIGVGAP. 
 
 
 
 
 
 
 
 
 
 
 
3. Results 
 
67 
 
 
 
 
 
 
 
 
 
The ions of interest were analyzed in ER mode to verify their charge state (Figure 3-26). 
 
 
Figure 3-26. ER spectra of m/z 704.4 (A), 721.4 (B) and 1056.0 (C). A) and C) correspond respectively to the 
triply- and doubly-charged ions of the N-terminal peptide C[alk]GNLSTC[alk]MLGTYTQDFNK; B) corresponds 
to the doubly-charged ion of the C-terminal peptide FHTFPQTAIGVGAP. 
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EPI and MS2 fragmentation spectra were acquired for the two peptides originated by the tryptic digestion 
of hCT (Figure 3-27, Figure 3-29, Figure 3-31). 
 
 
Figure 3-27. EPI (A) and MS2 (B) fragmentation spectra of calcitonin N-terminal peptide 
C[alk]GNLSTC[alk]MLGTYTQDFNK. The precursor ion is highlighted in blue. 
 
 
Figure 3-28. Fragment ion tables of calcitonin N-terminal peptide 
C[alk]GNLSTC[alk]MLGTYTQDFNK: theoretical monoisotopic mass values of singly- and 
doubly-charged b and y ions. From http://db.systemsbiology.net/proteomicsToolkit/ 
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Figure 3-29. EPI fragmentation spectra of calcitonin C-terminal peptide FHTFPQTAIGVGAP. The applied 
CE values are 30 (A) and 37 (B). The precursor ion is highlighted in green. 
 
 
Figure 3-30. Fragment ion tables of calcitonin C-terminal peptide 
FHTFPQTAIGVGAP: theoretical monoisotopic mass values of singly- and doubly-
charged b and y ions. From http://db.systemsbiology.net/proteomicsToolkit/ 
 
 
 
Figure 3-31. MS2 fragmentation spectrum of calcitonin C-terminal peptide FHTFPQTAIGVGAP. The 
precursor ion is highlighted in green. 
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MRM ANALYSIS 
The following transitions were analyzed: 
m/z 
precursor ion 
(Q1) 
m/z 
fragment ion 
(Q3) 
Fragment ion 
721.9 1328.2 b13(1+) 
721.9 665.0 b13(2+) 
721.9 629.4 b5(1+) 
1056.0 1074.3 y9(1+) 
1056.0 1187.2 y10(1+) 
1056.0 753.2 y6(1+) 
 
Linearity in the theoretical range of concentrations 0.5 – 50 µg/ml was tested and calibration curves were 
obtained (Figure 3-32 and Figure 3-33). 
 
 
Figure 3-32. Calibration curves obtained for calcitonin N-terminal peptide 
C[alk]GNLSTC[alk]MLGTYTQDFNK. 
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Figure 3-33. Calibration curves obtained for calcitonin C-terminal peptide FHTFPQTAIGVGAP. 
 
R
2
 values are ≥ 0.987 for each of the analyzed transitions of the C-terminal peptide FHTFPQTAIGVGAP. 
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Human procalcitonin 
The peptides originated by a virtual tryptic digestion of hPCT are reported in Table 3-7, together with 
their cleavage probabilities. 
 
 
Table 3-7. Tryptic digestion of hPCT: cleavage sites and cleavage probabilities. From 
http://web.expasy.org/peptide_cutter/ 
 
Protein denaturation in SDS 
Protocol based on SDS and thermal denaturation: 
- thawing of the protein standard: 10 µg of hPCT lyophilized in 10 mM phosphate buffer 
- solubilization in 100 mM ammonium bicarbonate 
- buffer exchange to 100 mM ammonium bicarbonate with Micro Bio-Spin Chromatography 
Columns 
- denaturation and reduction with 0.1% SDS and 9.5 mM TCEP, 5 minutes a 95 °C in the dark 
- alkylation in 17 mM IAA, 30 minutes at 25 °C in the dark 
- in-solution digestion with trypsin 1:20 (w/w), 16 hours at 37 °C 
- detergent removal with Pierce Detergent Removal Spin Columns 
- quenching of digestion by addition of 0.1% formic acid. 
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MALDI-TOF ANALYSIS 
 
The MALDI-TOF spectrum is characterized by the presence of signals which can be attributed to the 
tryptic digestion of hPCT (Figure 3-34). 
 
 
Figure 3-34. MALDI-TOF spectrum of digestion solution of hPCT. 
 
Peptide sequence 
Length 
(aa) 
Position 
Missed 
cleavages 
Theoretical 
monoisotopic 
molecular weight 
Experimental 
monoisotopic 
[M+H]
+
 
ASELEQEQER 10 38 – 47 - 1217.55 1218.5760 
DHRPHVSMPQNAN 13 104 – 116 1 1501.68 1502.7308 
LLLAALVQDYVQMK 14 24 – 37 - 1603.90 1604.9380 
SALESSPADPATLSEDEAR 19 5 – 23 - 1944.89 1945.9658 
ASELEQEQEREGSSLDSPR 19 38 – 56 1 2145.98 2147.1436 
DMSSDLERDHRPHVSMPQNAN 21 94 – 116 2 2435.07 2436.1614 
Sequence coverage = 62.9 % 
 
 
 
 
 
 
 
 
 
3. Results 
 
74 
 
 
 
 
 
Q TRAP INFUSION ANALYSIS 
 
The digestion solution was subjected to ZipTip C18 purification and then diluted 2x prior to Q TRAP 
analysis. EMS and Q1 full scan spectra were acquired (Figure 3-35). 
 
 
Figure 3-35. Comparison between the EMS spectrum (A) and the Q1 spectrum (B) of the digestion mixture. 
 
Tryptic digestion of hPCT produces peptides that ionize in ESI as multiply-charged ions. The most 
intense signals in the EMS and Q1 full scan spectra are: 
 [M+2H]2+ of peptide ASELEQEQER; 
 [M+3H]3+ of peptide ASELEQEQEREGSSLDSPR; 
 [M+3H]3+ of C-terminal peptide DMSSDLERDHRPHVSMPQNAN; 
 [M+2H]2+ of peptide SALESSPADPATLSEDEAR. 
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The ions of interest were analyzed in ER mode to verify their charge state (Figure 3-36). 
 
 
Figure 3-36. ER spectra of the multiply-charged peptides resulting from hPCT digestion. 
 
 
Peptide ASELEQEQER and peptide SALESSPADPATLSEDEAR were selected for MS/MS experiments 
(data not shown): 
 fragmentation of peptide ASELEQEQER produced y5, y6, y4, y7 and y8 fragment ions, listed 
in decreasing order of signal intensity; 
 fragmentation of peptide SALESSPADPATLSEDEAR produced y10, y11, y13 and y14 
fragment ions, listed in decreasing order of signal intensity. 
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Human C-reactive protein 
 
The peptides originated by a virtual tryptic digestion of hCRP are reported in Table 3-8, together with 
their cleavage probabilities. 
 
 
Table 3-8. Tryptic digestion of hCRP: cleavage sites and cleavage probabilities. From 
http://web.expasy.org/peptide_cutter/ 
 
Two different protein denaturation procedures were considered: a SDS-based denaturation and a 
urea/thiourea procedure. 
Protein denaturation in urea and thiourea mixture 
The first sample preparation procedure to be applied to hCRP was the one optimized for the digestion of 
hCT: 
- denaturation in 20 mM NH4HCO3, 6 M urea, 2 M thiourea 
- reduction in 48.75 mM DTT, 30 minutes at 25 °C 
- alkylation in 100 mM IAA, 30 minutes at 25 °C in the dark 
- desalting with GE Healthcare PD MiniTrap G-10 column 
- in-solution digestion: 16 hours at 37 °C with trypsin 1:50 (w/w) 
- quenching of digestion by addition of 0.1% formic acid. 
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MALDI-TOF ANALYSIS 
 
The MALDI-TOF spectrum is characterized by the presence of signals which can be attributed to the 
tryptic digestion of hCRP (Figure 3-37). 
 
 
Figure 3-37. MALDI-TOF spectrum of digestion solution of hCRP. 
 
Peptide sequence 
Length 
(aa) 
Position 
Missed 
cleavages 
Theoretical 
monoisotopic 
molecular weight 
Experimental 
monoisotopic 
[M+H]
+
 
AFVFPK 6 8 – 13 - 707.40 708.3991 
KAFVFPK 7 7 – 13 1 835.50 836.5038 
ESDTSYVSLK 10 14 – 23 - 1127.53 1128.5327 
GYSIFSYATK 10 48 – 57 - 1135.55 1136.5659 
GYSIFSYATKR 11 48 – 58 1 1291.66 1292.6761 
RQDNEILIFWSK 12 58 – 69 1 1547.81 1548.8270 
YEVQGEVFTKPQLWP 15 192 – 206 1 1819.91 1820.9221 
AFTVCLHFYTELSSTR 16 32 – 47 - 1873.90 1874.8694 
ESDTSYVSLKAPLTKPLK 18 14 – 31 2 1976.08 1977.0891 
ALKYEVQGEVFTKPQLWP 18 181 – 206 2 2132.13 2133.1350 
Sequence coverage = 39.3% 
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Q TRAP INFUSION ANALYSIS 
 
The digestion solution of hCRP was infused in the Q TRAP and analyzed in EMS and Q1 full scan modes 
(Figure 3-38). 
 
 
Figure 3-38. Comparison between the EMS spectrum (A) and the Q1 spectrum (B) of the digestion solution of 
hCRP. 
 
Tryptic digestion of hCRP produces peptides that ionize in ESI as multiply-charged ions. The most 
intense signals in EMS and Q1 full scan spectra are: 
 [M+2H]2+ of peptide ESDTSYVSLK; 
 [M+2H]2+ of peptide GYSIFSYATK; 
 [M+2H]2+ of peptide RQDNEILIFWSK; 
 [M+2H]2+ of C-terminal peptide YEVQGEVFTKPQLWP; 
 [M+2H]2+ of C-terminal peptide ALKYEVQGEVFTKPQLWP. 
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The ions of interest were analyzed in ER mode to verify their charge state (Figure 3-39). 
 
 
Figure 3-39. ER spectra of multiply-charged peptides resulting from hCRP digestion. 
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MS/MS ANALYSIS 
 
Two peptides were selected for MS/MS analysis on the basis of their signal intensity in the Q1 full scan: 
peptide GYSIFSYATK and peptide ESDTSYVSLK. MS
E
 and MS2 spectra were acquired (Figure 3-40, 
Figure 3-41, Figure 3-43, Figure 3-44). 
 
 
 
Figure 3-40. MS
E
 spectra of peptide ESDTSYVSLK. The low energy function is reported in (D). A wide range of 
CE values have been tested: 10 – 25 (A), 20 – 35 (B) and 30 – 45 (C). 
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Figure 3-41. MS2 fragmentation spectrum of peptide ESDTSYVSLK. The precursor ion is highlighted in red. 
 
 
 
Figure 3-42. Fragment ion tables of peptide ESDTSYVSLK: theoretical monoisotopic mass 
values of singly- and doubly-charged b and y ions. From 
http://db.systemsbiology.net/proteomicsToolkit/ 
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Figure 3-43. MS
E
 spectra of peptide GYSIFSYATK. The low energy function is reported in (D). A wide range of 
CE values have been tested: 10 – 25 (A), 20 – 35 (B) and 30 – 45 (C). 
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Figure 3-44. MS2 fragmentation spectrum of peptide GYSIFSYATK. The precursor ion is highlighted in purple. 
 
 
 
Figure 3-45. Fragment ion tables of peptide GYSIFSYATK: theoretical monoisotopic mass 
values of singly- and doubly-charged b and y ions. From 
http://db.systemsbiology.net/proteomicsToolkit/ 
 
 
MRM ANALYSIS 
 
The following transitions were analyzed: 
m/z 
precursor ion 
(Q1) 
m/z 
fragment ion 
(Q3) 
Fragment ion 
565.0 609.8 y5(1+) 
565.0 696.8 y6(1+) 
565.0 913.0 y8(1+) 
565.0 797.9 y7(1+) 
569.8 918.1 y8(1+) 
569.8 717.1 y6(1+) 
569.8 831.0 y7(1+) 
 
Linearity in the theoretical range of concentrations 2.5 – 50 µg/ml was tested and calibration curves were 
obtained (Figure 3-46). 
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Figure 3-46. Calibration curves obtained for hCRP peptide ESDTSYVSLK. 
 
R
2
 values are ≥ 0.995 for each of the analyzed transitions of peptide ESDTSYVSLK. 
 
Protein denaturation in SDS 
Two different protocols have been tested, differing in the strategy exploited to reduce the detergent 
concentration prior to the digestion step: 
 protocol 1: sample purification with Detergent Removal Spin Column 
 protocol 2: sample dilution with reaction buffer. 
 
Protocol 1: 
- buffer exchange with Micro Bio-Spin Columns BIO-RAD (from 140 mM NaCl, 20 mM Tris-HCl, 2 
mM CaCl2, 0.05% NaN3, pH 7.5 to 200 mM NH4HCO3) 
- denaturation in 100 mM NH4HCO3, 0.1% SDS 
- reduction in 9.5 mM TCEP, 1 hour at 55 °C in the dark 
- alkylation in 17 mM IAA, 30 minutes at 25 °C in the dark 
- Pierce Detergent Removal Spin Column → elution in 20 mM NH4HCO3 
- in-solution digestion: 16 hours at 37 °C with trypsin 1:50 (w/w) 
- quenching of digestion by addition of 0.1% formic acid. 
 
MALDI-TOF ANALYSIS 
The MALDI-TOF spectrum is characterized by the presence of signals which can be attributed to the 
tryptic digestion of hCRP (Figure 3-47). 
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Figure 3-47. MALDI-TOF spectrum of digestion solution of hCRP. 
 
Peptide sequence 
Length 
(aa) 
Position 
Missed 
cleavages 
Theoretical 
monoisotopic 
molecular weight 
Experimental 
monoisotopic 
[M+H]
+
 
AFVFPK 6 8 – 13 - 707.40 708.3929 
KAFVFPK 7 7 – 13 1 835.50 836.4863 
APLTKPLK 8 24 – 31 1 866.56 867.5520 
ESDTSYVSLK 10 14 – 23 - 1127.53 1128.5251 
GYSIFSYATK 10 48 – 57 - 1135.55 1136.5428 
GYSIFSYATKR 11 48 – 58 1 1291.66 1292.6451 
QDNEILIFWSK 11 59 – 69 - 1391.71 1392.6949 
RQDNEILIFWSK 12 58 – 69 1 1547.81 1548.8010 
YEVQGEVFTKPQLWP 15 192 – 206 1 1819.91 1820.9064 
AFTVCLHFYTELSSTR 16 32 – 47 - 1873.90 1874.8275 
AFTVC[alk]LHFYTELSSTR 16 32 – 47 - 1930.92 1931.9175 
ALKYEVQGEVFTKPQLWP 18 181 – 206 2 2132.13 2133.1270 
Sequence coverage = 39.3% 
 
 
Protocol 2: 
- buffer exchange with Micro Bio-Spin Columns BIO-RAD (from 140 mM NaCl, 20 mM Tris-HCl, 2 
mM CaCl2, 0.05% NaN3, pH 7.5 to 100 mM NH4HCO3) 
- denaturation and reduction in 100 mM NH4HCO3, 0.1% SDS, 9.5 mM TCEP, 5 minutes at 95 °C 
in the dark 
- alkylation in 17 mM IAA, 30 minutes at 25 °C in the dark 
- sample dilution 2x in 100 mM ammonium bicarbonate 
- in-solution digestion: 16 hours at 37 °C with trypsin 1:25 (w/w) 
- quenching of digestion by addition of 0.1% formic acid. 
MALDI-TOF ANALYSIS 
Desalting of the digestion solution of hCRP prior to MALDI-TOF analysis was performed using a ZipTip 
C18 Pipette Tip. The MALDI-TOF spectrum is characterized by the presence of signals which can be 
attributed to the tryptic digestion of hCRP (Figure 3-48). 
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Figure 3-48. MALDI-TOF spectrum of digestion solution of hCRP. 
 
Peptide sequence 
Length 
(aa) 
Position 
Missed 
cleavages 
Theoretical 
monoisotopic 
molecular weight 
Experimental 
monoisotopic 
[M+H]
+
 
AFVFPK 6 8 – 13 - 707.40 708.4016 
KAFVFPK 7 7 – 13 1 835.50 386.5032 
APLTKPLK 8 24 – 31 1 866.56 867.5617 
GYSIFSYATK 10 48 – 57 - 1135.55 1136.5702 
GYSIFSYATKR 11 48 – 58 1 1291.66 1292.6759 
YEVQGEVFTKPQLWP 15 192 – 206 1 1819.91 1820.9341 
ESDTSYVSLKAPLTKPLK 18 14 – 31 2 1976.08 1977.1066 
ALKYEVQGEVFTKPQLWP 18 181 – 206 2 2132.13 2133.1594 
Sequence coverage = 26.2% 
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TARGETED ANALYSES IN ORGANIC-AQUEOUS SOLUTION 
Human calcitonin 
Digestion of the reduced and alkylated protein 
Sample preparation: 
- 20x dilution of the stock solution of CT 1 mg/ml with the mixed organic-aqueous solvent system 
- reduction in 5 mM TCEP, 5 minutes at 25 °C in the dark 
- alkylation in 17 mM IAA, 30 minutes at 25°C in the dark 
- quenching of alkylation by addition of 5 mM DTT, 15 minutes at 25 °C 
- in-solution digestion: 1 hour at 37 °C with trypsin 1:20 (w/w) 
- quenching of digestion by addition of 0.1% formic acid. 
The mixed organic-aqueous solvent systems tested are: 
a) 60% ACN / 40% 20 mM ammonium bicarbonate 
b) 80% ACN / 20% 20 mM ammonium bicarbonate 
c) 60% methanol / 40% 20 mM ammonium bicarbonate 
d) 80% methanol / 20% 20 mM ammonium bicarbonate. 
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MALDI-TOF ANALYSIS 
 
Figure 3-49. MALDI-TOF spectra of the digestion solution of hCT in 60% ACN (A), 80% ACN (B), 
60% methanol (C) and 80% methanol (D). 
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In each of the solvent systems tested hCT essentially remains intact. Reduction of disulfide bonds and 
alkylation of Cys residues occurs to a variable extent depending on the type of organic solvent used and 
its concentration in the reaction mixture: the best results were obtained in the solvent system 60% ACN / 
40% 50 mM ammonium bicarbonate (Figure 3-49). The results obtained suggest that in 60% ACN hCT 
adopts a conformation in which the Cys residues (N-terminal portion of the protein) are exposed to the 
solvent, whereas the unique cleavage site (Lys18) is hindered. 
Taking into account this observation, a different sample preparation protocol was designed to verify 
whether a change in the ACN concentration in the reaction mixture just prior to the addition of trypsin 
could improve digestion yield by altering hCT conformation. 
Sample preparation: 
- 20x dilution of hCT stock solution 1 mg/ml with 60% ACN / 40% 50 mM ammonium bicarbonate 
- reduction in 5 mM TCEP, 5 minutes at 25 °C 
- alkylation in 17 mM IAA, 30 minutes at 25°C in the dark 
- quenching of alkylation by addition of 5 mM DTT, 15 minutes at 25 °C 
- 3x dilution of sample with 50 mM ammonium bicarbonate to reduce the ACN concentration to 20% 
- split the solution in two aliquots 
- in-solution digestion: 1 hour at 37 °C with trypsin 1:20 and 1:5 (w/w) 
- quenching of digestion by addition of 0.1% formic acid. 
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MALDI-TOF ANALYSIS 
 
Figure 3-50. MALDI-TOF spectra of the digestion solutions of hCT in 20% ACN with trypsin to 
protein ratio 1:20 (A) and 1:5 (B). 
Even though a large part of hCT is still undigested, the spectra of the digestion solutions of hCT in 20% 
ACN show signals of its two constituent peptides (m/z 1441.7 and 2109.8), which appear more intense 
when trypsin to protein ratio is increased from 1:20 to 1:5 (Figure 3-50). This result is an evidence of the 
change in hCT conformation produced by the reduction of the ACN concentration in the reaction 
solution: in this environment the cleavage site (Lys18) is more exposed to the action of the proteolytic 
enzyme, although longer times are required for the reaction to be complete. 
Digestion in 60% ACN 
Digestion of hCT in 60% ACN / 40% 50 mM ammonium bicarbonate with trypsin to protein ratio 1:5, 
without previous reduction of disulfide bonds and alkylation of Cys residues, was tested and monitored 
over time (15 – 90 minutes) (Figure 3-51). 
Sample preparation: 
- 20x dilution of the stock solution of CT 1 mg/ml with 60% ACN / 40% ammonium bicarbonate 
- in-solution digestion with trypsin to protein ratio 1:5 (w/w) at 37 °C 
- quenching of digestion by addition of 0.1% formic acid after 15, 30, 60 and 90 minutes. 
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MALDI-TOF ANALYSIS 
 
Figure 3-51. MALDI-TOF spectra of the digestion solutions of hCT in 60% ACN after 
15 minutes (A), 30 minutes (B), 60 minutes (C) and 90 minutes (D). 
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Peptide 
Length 
(aa) 
Position 
Theoretical 
monoisotopic 
molecular weight 
Experimental 
monoisotopic 
[M+H]
+
 
Intact human calcitonin 32 1 – 32 3418.58 3416.5 
 
The theoretical monoisotopic molecular weight reported in the upper table was calculated on the basis of 
the amino acidic sequence, but because of the disulfide bond between cysteine 1 and 7 and the amidated 
C-terminal proline, the effective theoretical monoisotopic molecular weight of intact human calcitonin is 
3415.5789 Da. Therefore, the experimental monoisotopic weight observed is in good agreement with the 
expected one. hCT is essentially still undigested after 1 hour of reaction. 
 
Q TRAP INFUSION ANALYSIS 
The digestion solution of hCT after 1 hour of reaction was infused in the Q TRAP and analyzed in Q1 and 
EMS mode (data not shown). The m/z value of the most abundant ion in the full scan spectra was 
compatible with the one expected for the triply-charged ion of the intact protein. Therefore an ER 
spectrum was acquired, which confirmed the triply-charged state of the ion of interest (Figure 3-52). 
 
Figure 3-52. ER spectrum of m/z 1140.2, the triply-charged ion of intact hCT. 
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MS/MS ANALYSIS 
 
MS/MS analysis of intact hCT was performed: MS
E
, EPI and MS2 spectra were acquired (Figure 3-53, 
Figure 3-54, Figure 3-56). 
 
 
 
Figure 3-53. MS
E
 spectra of hCT. The low energy function is reported in (D). A wide range of CE values have 
been tested: 15 – 30 (A), 25 – 40 (B) and 30 – 45 (C). 
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Figure 3-54. EPI fragmentation spectra of hCT. Increasing CE values were applied: 30 (A), 35 (B) and 40 (C). 
The precursor ion is highlighted in pink. 
 
 
Figure 3-55. Fragment ion tables of hCT: theoretical monoisotopic mass values of singly-, doubly- and triply-charged 
b and y ions. From http://db.systemsbiology.net/proteomicsToolkit/ 
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Figure 3-56. MS2 fragmentation spectra of hCT. Increasing CE values were applied: 30 (A), 35 (B) and 40 (C). 
The precursor ion is highlighted in pink. 
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MRM ANALYSIS 
 
The following transitions were analyzed: 
m/z 
precursor ion 
(Q1) 
m/z 
fragment ion 
(Q3) 
Fragment ion 
1141.2 1654.0 b31(2+) 
1141.2 1103.4 b31(3+) 
1141.2 1079.8 b30(3+) 
 
Linearity in the theoretical range of concentrations 0.1 – 12.5 µg/ml was tested and calibration curves 
were obtained (Figure 3-57). 
 
 
Figure 3-57. Calibration curves obtained for intact hCT. 
 
The transition 1141.2/1103.4 featured the best linearity (R
2
 = 0.997). 
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Human procalcitonin 
Digestion in 60% ACN 
Digestion of hPCT was performed in 60% ACN / 40% 50 mM ammonium bicarbonate, which 
represented the best choice among the mixed organic-aqueous solvent systems tested for hCT. 
Abrupt digestion in the above mentioned reaction solution with trypsin to protein ratio 1:5, without 
previous reduction of disulfide bonds and alkylation of Cys residues, was monitored over time (15 – 90 
minutes) (Figure 3-58). 
Sample preparation: 
- solubilization of the protein standard (10 µg) in 50 mM ammonium bicarbonate: 100 µl of stock 
solution 0.1 mg/ml 
- 2.5x dilution of 50 µl of the stock solution with ACN: PCT 40 µg/ml in 60% ACN / 40% 50 mM 
ammonium bicarbonate 
- in-solution digestion with trypsin 1:5 (w/w) at 37 °C 
- quenching of digestion by addition of 0.1% formic acid after 15, 30, 60 and 90 minutes. 
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MALDI-TOF ANALYSIS 
 
Figure 3-58. MALDI-TOF spectra of the digestion solution of hPCT after 15 minutes (A), 30 
minutes (B), 60 minutes (C) and 90 minutes (D). 
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The MALDI-TOF spectrum after 1 hour of reaction was analyzed looking for signals which could be 
attributed to the tryptic digestion of hPCT (Figure 3-59). 
 
 
Figure 3-59. MALDI-TOF spectrum of digestion solution of hPCT in 60% ACN after 1 hour of reaction. 
 
Peptide sequence 
Length 
(aa) 
Position 
Missed 
cleavages 
Theoretical 
monoisotopic 
molecular weight 
Experimental 
monoisotopic 
[M+H]
+
 
EGSSLDSPR 9 48 – 56 - 946.44 947.4082 
ASELEQEQER 10 38 – 47 - 1217.55 1218.9954 
DHRPHVSMPQNAN 13 104 – 116 1 1501.68 1502.6367 
FHTFPQTAIGVGAPGK 16 78 – 93 - 1626.85 1627.8016 
FHTFPQTAIGVGAPGKK 17 78 – 94 1 1754.95 1755.9832 
FHTFPQTAIGVGAPGKKR 18 78 – 95 2 1911.05 1911.9885 
ASELEQEQEREGSSLDSPR 19 38 – 56 1 2145.98 2146.9153 
DMSSDLERDHRPHVSMPQNAN 21 96 – 116 2 2435.07 2436.0066 
RDMSSDLERDHRPHVSMPQNAN 22 95 – 116 3 2591.17 2592.1050 
KRDMSSDLERDHRPHVSMPQNAN 23 94 – 116 4 2719.20 2720.2068 
Sequence coverage = 50% 
 
The peptides of interest are present even after just 15 minutes of reaction. 
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Q TRAP INFUSION ANALYSIS 
 
Desalting of the digestion solution of hPCT prior to Q TRAP infusion analysis was performed using 
Pierce C18 Spin Columns, Thermo Scientific. The sample was analyzed in Q1 and EMS mode (data not 
shown). The m/z value of the most abundant ion in the full scan spectra was compatible with the one 
expected for the triply-charged ion of C-terminal peptide DMSSDLERDHRPHVSMPQNAN. Therefore 
an ER spectrum was acquired, which confirmed the triply-charged state of the ion of interest (Figure 
3-60). 
 
 
Figure 3-60. ER spectrum of the triply-charged ion of peptide DMSSDLERDHRPHVSMPQNAN. 
 
 
MS/MS ANALYSIS 
 
MS/MS analyses were performed to confirm the identity of the ion of interest as the C-terminal peptide 
DMSSDLERDHRPHVSMPQNAN. MALDI-TOF/TOF, MS
E
, EPI and MS2 spectra were acquired 
(Figure 3-61, Figure 3-62, Figure 3-63, Figure 3-65). 
 
 
Figure 3-61. MALDI-TOF/TOF spectrum of peptide DMSSDLERDHRPHVSMPQNAN. 
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Figure 3-62. MS
E
 spectra of peptide DMSSDLERDHRPHVSMPQNAN. The low energy function is reported in 
(C). Different ranges of CE values have been tested: 15 – 30 (A) and 20 – 35 (B). 
 
 
 
 
Figure 3-63. EPI fragmentation spectrum of C-terminal peptide DMSSDLERDHRPHVSMPQNAN. The 
precursor ion is highlighted in yellow. 
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Figure 3-64. Fragment ion tables of C-terminal peptide DMSSDLERDHRPHVSMPQNAN: theoretical 
monoisotopic mass values of singly-, doubly- and triply-charged b and y ions. From 
http://db.systemsbiology.net/proteomicsToolkit/ 
 
 
Figure 3-65. MS2 fragmentation spectra of C-terminal peptide DMSSDLERDHRPHVSMPQNAN. The 
applied CE values are 35 (A) and 40 (B). The precursor ion is highlighted in yellow. 
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Human C-reactive protein 
Digestion of hCRP was performed in 60% ACN / 40% 50 mM ammonium bicarbonate, which 
represented the best choice among the mixed organic-aqueous solvent systems tested for hCT. Two 
different trypsin to protein ratios were tested, 1:20 and 1:5 (Figure 3-66). 
Digestion of the reduced and alkylated protein in 60% ACN 
Sample preparation: 
- 20x dilution of the stock solution of CRP 1 mg/ml with 60% ACN / 40% 50 mM ammonium 
bicarbonate 
- reduction in 5 mM TCEP, 5 minutes at 25 °C in the dark 
- alkylation in 17 mM IAA, 30 minutes at 25°C in the dark 
- quenching of alkylation by addition of 5 mM DTT, 15 minutes at 25 °C 
- split the solution in two aliquots 
- in-solution digestion: 1 hour at 37 °C with trypsin 1:20 and 1:5 (w/w) 
- quenching of digestion by addition of 0.1% formic acid. 
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MALDI-TOF ANALYSIS 
 
Figure 3-66. MALDI-TOF spectra of the digestion solutions of hCRP in 60% ACN with trypsin to 
protein ratio 1:20 (A) and 1:5 (B). 
 
The MALDI-TOF spectra of the digestion solutions were analyzed to look for the presence of signals 
which can be attributed to hCRP peptides: 
Peptide sequence 
Length 
(aa) 
Position 
Missed 
cleavages 
Theoretical 
monoisotopic 
molecular weight 
Experimental 
monoisotopic 
[M+H]
+
 
KAFVFPK 7 7 – 13 1 835.50 836.4657 
GYSIFSYATK 10 48 – 57 - 1135.55 1136.5061 
GYSIFSYATKR 11 48 – 58 1 1291.66 1292.6123 
QDNEILIFWSK 11 59 – 69 - 1391.71 1392.6337 
RQDNEILIFWSK 12 58 – 69 1 1547.81 1548.7499 
YEVQGEVFTKPQLWP 15 192 – 206 1 1819.91 1820.8497 
ESDTSYVSLKAPLTKPLK 18 14 – 31 2 1976.08 1977.0070 
ALKYEVQGEVFTKPQLWP 18 181 – 206 2 2132.13 2133.0623 
Sequence coverage = 31.6% 
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The lower the trypsin to protein ratio is, the poorer the digestion yield of peptides RQDNEILIFWSK (m/z 
1548.8) and ALKYEVQGEVFTKPQLWP (m/z 2133.1). 
 
 
 
Digestion of hCRP in 60% ACN / 40% 50 mM ammonium bicarbonate with trypsin to protein ratio 1:5, 
with previous reduction of disulfide bonds and alkylation of Cys residues, was monitored over time (15 – 
90 minutes) (Figure 3-67). 
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MALDI-TOF ANALYSIS 
 
Figure 3-67. MALDI-TOF spectra of the digestion solution of hCRP after 15 minutes (A), 
30 minutes (B), 60 minutes (C) and 90 minutes (D). 
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Digestion in 60% ACN 
Digestion of hCRP in 60% ACN / 40% 50 mM ammonium bicarbonate with trypsin to protein ratio 1:5, 
without previous reduction of disulfide bonds and alkylation of Cys residues, was monitored over time 
(15 – 90 minutes) (Figure 3-68). 
Sample preparation: 
- 20x dilution of the stock solution of CRP 1 mg/ml with 60% CAN / 40% 50 mM ammonium 
bicarbonate, pH 8 
- in-solution digestion with trypsin 1:5 (w/w) at 37 °C 
- quenching of digestion by addition of 0.1% formic acid after 15, 30, 60 and 90 minutes. 
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MALDI-TOF ANALYSIS 
 
Figure 3-68. MALDI-TOF spectra of the digestion solution of hCRP in 60% ACN after 
15 minutes (A), 30 minutes (B), 60 minutes (C) and 90 minutes (D). 
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The MALDI-TOF spectrum of the digestion solution after one hour of reaction was analyzed (Figure 
3-69) and compared to the spectra acquired at different reaction times. 
 
Figure 3-69. MALDI-TOF spectrum of digestion solution of hCRP in 60% ACN after 1 hour of reaction. 
 
Peptide sequence 
Length 
(aa) 
Position 
Missed 
cleavages 
Theoretical 
monoisotopic 
molecular weight 
Experimental 
monoisotopic 
[M+H]
+
 
KAFVFPK 7 7 – 13 1 835.50 836.4642 
GYSIFSYATK 10 48 – 57 - 1135.55 1136.5197 
GYSIFSYATKR 11 48 – 58 1 1291.66 1292.6254 
QDNEILIFWSK 11 59 – 69 - 1391.71 1392.6782 
RQDNEILIFWSK 12 58 – 69 1 1547.81 1548.7888 
YEVQGEVFTKPQLWP 15 192 – 206 1 1819.91 1820.8918 
ESDTSYVSLKAPLTKPLK 18 14 – 31 2 1976.08 1977.0453 
ALKYEVQGEVFTKPQLWP 18 181 – 206 2 2132.13 2133.1113 
Sequence coverage = 31.6% 
 
The peptides of interest, RQDNEILIFWSK and ALKYEVQGEVFTKPQLWP, are present even after just 
15 minutes of reaction. 
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MS/MS ANALYSIS 
 
MS/MS analyses were performed to confirm the identity of the ions of interest as the peptides 
RQDNEILIFWSK and ALKYEVQGEVFTKPQLWP. MALDI-TOF/TOF and MS
E
 spectra were 
acquired (Figure 3-70, Figure 3-72, Figure 3-71, Figure 3-74). 
 
 
 
Figure 3-70. MALDI-TOF/TOF spectrum of peptide RQDNEILIFWSK. 
 
 
Figure 3-71. MALDI-TOF/TOF spectrum of C-terminal peptide ALKYEVQGEVFTKPQLWP. 
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Figure 3-72. MS
E
 spectra of peptide RQDNEILIFWSK. The low energy function is reported in (D). A wide 
range of CE values have been tested: 15 – 30 (A), 25 – 40 (B) and 30 – 45 (C). 
 
 
Figure 3-73. Fragment ion tables of peptide RQDNEILIFWSK: theoretical monoisotopic mass values of singly-, 
doubly- and triply-charged b and y ions. From http://db.systemsbiology.net/proteomicsToolkit/ 
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Figure 3-74. MS
E
 spectra of C-terminal peptide ALKYEVQGEVFTKPQLWP. The low energy function is 
reported in (D). A wide range of CE values have been tested: 10 – 25 (A), 20 – 35 (B) and 30 – 45 (C). 
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Figure 3-75. Fragment ion tables of C-terminal peptide ALKYEVQGEVFTKPQLWP: theoretical 
monoisotopic mass values of singly-, doubly- and triply-charged b and y ions. From 
http://db.systemsbiology.net/proteomicsToolkit/ 
 
 
 
Q TRAP INFUSION ANALYSIS 
 
Peptides RQDNEILIFWSK and ALKYEVQGEVFTKPQLWP were also fragmented in MS2 mode (data 
not shown): 
 fragmentation of peptide RQDNEILIFWSK produced b7, b8 and b9 fragment ions, listed in 
decreasing order of signal intensity; 
 fragmentation of peptide ALKYEVQGEVFTKPQLWP produced b17(2+), b10 and b16(2+) 
fragment ions, listed in decreasing order of signal intensity. 
 
 
 
MRM ANALYSIS 
 
The following transitions were analyzed: 
m/z 
precursor ion 
(Q1) 
m/z 
fragment ion 
(Q3) 
Fragment ion 
776.7 1130.4 b9(1+) 
776.7 870.1 b7(1+) 
776.7 983.3 b8(1+) 
712.9 917.5 b16(2+) 
712.9 1010.7 b17(2+) 
712.9 1118.1 b10(1+) 
 
Linearity in the theoretical range of concentrations 2.5 – 50 µg/ml was tested and calibration curves were 
obtained (Figure 3-76). 
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Figure 3-76. Calibration curves obtained for hCRP peptide RQDNEILIFWSK. 
 
The transition of peptide RQDNEILIFWSK 776.7/983.3 featured the best linearity (R
2
 = 0.996). 
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3.3. ANALYSIS OF PEPTIDES 
The main characteristics of peptides originated by tryptic digestion of human calcitonin, human 
procalcitonin and human C-reactive protein in aqueous and organic-aqueous solutions were analyzed. 
Table 3-9 shows for each peptide its amino acidic sequence and its length, the theoretical monoisotopic 
molecular weight, the isoelectric point, the aliphatic index and the composition in 
hydrophobic/polar/basic/acidic residues. 
 
 
Table 3-9. Table showing the main characteristics of peptides originated by tryptic digestion of human 
calcitonin, human procalcitonin and human C-reactive protein. The peptides whose cleavage is particularly 
favored in aqueous solution or in mixed organic-aqueous solvent system are reported in blue and green 
respectively. 
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3.4. CHOICE OF THE STATIONARY PHASE 
LC-MS analyses of the protein standards digested in mixed organic-aqueous solutions were performed 
after having tested a selection of columns, specific for peptide mixtures and suitable for both HPLC and 
UHPLC instrumentation, looking for the most fit for purpose stationary phase: three are based on the 
fused-core technology (Aeris Peptide XB-C18, Ascentis Express Peptide ES-C18, Halo Peptide ES-C18), 
whereas one is characterized by the Charged-Surface Hybrid technology (XSelect CSH 130) (Table 3-9). 
 
Table 3-10. Table reporting the main features of the LC columns tested. 
Column name SP Particle size 
(μm) 
Pore size 
(Å) 
Length 
(mm) 
I. D. 
(mm) 
Brand 
Aeris Peptide C18 3.6 100 150 2.1 Phenomenex 
Ascentis Express C18 2.7 160 150 4.6 SIGMA 
HALO ES-C18 C18 2.7 160 150 2.1 CPS 
XSelect CSH 130 C18 2.5 130 150 4.6 Waters 
 
 
Digestion solutions of hCRP and hCT in 60% ACN / 40% 50 mM ammonium bicarbonate were injected 
and analyzed in methanol gradient. 
 
 
Retention times and peak areas of the tryptic peptides of interest were monitored and compared (Table 
3-11, Figure 3-77 and Figure 3-78). 
 
 
 
Table 3-11. Table reporting the retention times of hCT and hCRP peptides. Peptides are listed in increasing 
order of monoisotopic molecular weight. 
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Figure 3-77. LC-MS
E
 analysis of hCRP peptides with various C18 stationary phases. The 
stationary phases tested are Halo Peptide ES-C18 (CPS), XSelect CSH 130 (Waters), Aeris 
PEPTIDE (Phenomenex) and Ascentis Express (SIGMA). Peptide 1 = ESDTSYVSLK, peptide 
2 = GYSIFSYATK, peptide 3 = RQDNEILIFWSK, peptide 4 = ESDTSYVSLKAPLTKPLK 
and peptide 5 = ALKYEVQGEVFTKPQLWP. 
 
 
 
Figure 3-78. LC-MS
E
 analysis of intact hCT with various C18 stationary phases. 
The stationary phases tested are Halo Peptide ES-C18 (CPS), XSelect CSH 130 
(Waters), Aeris PEPTIDE (Phenomenex) and Ascentis Express (SIGMA). 
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3.5. ANALYSIS OF THE MATRIX EFFECT 
The general term matrix refers to the components of a sample other than the analyte. Evaluation of the 
matrix effect, that is the change (suppression or enhancement) in the LC-MS response of a specific 
analyte compared to the analysis of the pure standard, is a necessary stage in the process of validation of 
bioanalytical methods. 
In this thesis a preliminary investigation of the matrix effect was performed using a pooled sample. The 
pool was created merging the extraction solutions of samples collected from five healthy newborns on 
their second day after birth (Table 3-12). 
 
Table 3-12. Clinical data of five healthy newborns. The extraction solutions of the samples collected on 
their second day after birth were merged to create a pool. 
 
 
The pool, representative of an healthy state, was digested in aqueous solution and analyzed: calcitonin, 
procalcitonin and C-reactive protein, if present, were not detectable. Therefore the digested pooled 
sample was spiked with hCT or hCRP protein standards, both separately digested in 60% ACN / 40% 50 
mM ammonium bicarbonate, to verify how the matrix influences the detection and quantitation of the 
analytes of interest. The pooled sample digested in aqueous solution was at first diluted with ACN, so that 
the solution reached the final composition of 60% ACN / 40% 50 mM ammonium bicarbonate, and then 
separately spiked with digested hCT or hCRP at different concentrations while keeping constant its 
concentration (60 µg/ml). The upper limits of the calibration curves previously obtained in the analyses of 
the protein standards alone were taken as the maximum concentrations ([hCT] = 12.5 µg/ml and [hCRP] 
= 50 µg/ml) and considered equal to 120%. The two successive dilutions represented the 100% and 80% 
solutions (Figure 3-79 and Figure 3-80). 
 
Figure 3-79. Scheme of the successive dilutions of hCT digestion solution, reporting the 
injected protein quantities. 
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Figure 3-80. Scheme of the successive dilutions of hCRP digestion solution, reporting the 
injected protein quantities. 
 
Retention times and peak areas of the proteotypic peptides were monitored. 
Calcitonin 
The retention time of intact hCT was increased of one minute. Furthermore, the peaks appeared 
broadened and pronged (Figure 3-81). This may be due to a combination of both matrix effect and 
column carryover. 
 
 
Figure 3-81. Comparison between hCT control (upper box) and the sample spiked at the 
maximum concentration (bottom box). 
 
The matrix factor and the variation in hCT peak area values observed between the control and the spiked 
sample are reported in Table 3-13. 
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Table 3-13. Table reporting the matrix factor (MF) and the variation in hCT 
peak area values observed between the control and the spiked sample. 
Transition Concentration (µg/ml) MF Δ area (%)* 
1141.2 / 1654.0 
8.33 0.8 20.1 
10.42 0.9 7.7 
12.50 0.8 15.1 
1141.2 / 1103.4 
8.33 0.8 22.7 
10.42 0.9 10.8 
12.50 0.8 16.0 
1141.2 / 1079.8 
8.33 0.7 25.8 
10.42 0.9 9.5 
12.50 0.8 17.8 
* (control-spiked)/control 
C-reactive protein 
The retention time of both hCRP proteotypic peptides was increased of 1.2 minutes. The matrix factor 
and the variation in peak area values observed between the control and the spiked sample are reported in 
Table 3-14. 
 
Table 3-14. Table reporting the matrix factor (MF) and the variation in the peak 
area values observed between the control and the spiked sample for the two hCRP 
proteotypic peptides RQDNEILIFWSK (m/z 776.7) and 
ALKYEVQGEVFTKPQLWP (m/z 712.9). 
Transition Concentration (µg/ml) MF Δ area (%)* 
776.7 / 1130.4 
33.33 1.1 -9.5 
41.67 1.2 -16.9 
50.00 1.2 -24.0 
776.7 / 870.1 
33.33 1.1 -13.3 
41.67 1.1 -14.6 
50.00 1.2 -22.2 
776.7 / 983.3 
33.33 1.1 -6.8 
41.67 1.2 -19.9 
50.00 1.2 -19.1 
712.9 / 917.5 
33.33 0.7 31.1 
41.67 0.7 26.8 
50.00 0.8 18.2 
712.9 / 1010.7 
33.33 0.7 28.3 
41.67 0.7 25.3 
50.00 0.8 17.7 
712.9 / 1118.1 
33.33 0.7 32.1 
41.67 0.7 26.1 
50.00 0.8 22.4 
* (control-spiked)/control 
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4.1. GEL-BASED APPROACHES 
Early-onset sepsis (EOS), defined as a septic state manifested in the first three days of life, is one of the 
major causes of neonatal mortality and surviving infants are at increased risk for developing morbidities, 
including bronchopulmonary dysplasia, prolonged hospital stay, and neurodevelopmental impairment 
[56]. Therefore, the availability of diagnostic tools allowing the early detection of an ongoing infective 
state represents an urgency in neonatal clinical care units. 
 
In this thesis, untargeted gel-based approaches were explored to conduct qualitative investigation of the 
salivary proteins in samples collected from healthy newborns in their early 48 hours after birth. This 
investigation is instrumental to the comparison between healthy newborns and newborns affected by 
bacterial infection. In particular the aims of this phase of the study were the description of the overall 
protein profile and the identification of the most abundant proteins, as well as the clarification of the 
differences, if present, occurring between samples collected in the first and in the second day of life. Both 
2D-PAGE – MALDI-TOF/TOF and SDS-PAGE – LC-(HR)MS/MS analyses were performed in order to 
collect complementary information. The investigation proceeded through several steps. 
 
Initially 2-DE analyses were performed on single newborns in the pH range 4 – 7. As expected, the 
comparison between images acquired after Coomassie and Silver staining revealed that the latter is 
characterized by greater sensitivity, since on average it helped to visualize more than 60% of the number 
of spots detected with Coomassie. The MALDI-TOF analyses of the digestion solutions of the excised 
spots led to define the identity of the most abundant proteins in the oral fluid samples: polymeric 
immunoglobulin receptor (PIGR), serum albumin, keratin and actin, all present in multiple isoforms 
(Figure 3-3). Due to the low amount of sample at our disposal (15 µg loaded per gel), a special care was 
put on the definition of protein identification guidelines: protein score (C. I. %) when different from zero, 
peptide count preferably greater than three, agreement between experimental and theoretical molecular 
weight and isoelectric point, as well as reproducibility of outcome between replicate spots, between 
different sample preparations and between different databases (Swiss-Prot and NCBI). 
 
2-DE analyses of pools were later performed. This produced a few advantages: pool analyses give a 
simplified picture of general conditions (e. g. healthy or pathological states); the higher total protein 
amount not only enables to use longer IPG strips, characterized by higher resolution of protein spots on 
the gel, but also leads to an increase in the number of Coomassie detectable spots and better chance of 
identification (avoiding the use of Silver staining). Furthermore, the depletion of the most abundant 
proteins prior to 2-DE (e. g. keratins) becomes an attractive chance. 
 
Feasibility of a SDS-PAGE – LC-(HR)MS/MS approach was verified analyzing a single saliva sample. 
Protein identifications were based on high resolution MS/MS data and agreement between the theoretical 
and the experimental molecular weight, the latter being not a necessary condition. The approach 
combining SDS-PAGE and LC-(HR)MS/MS analysis proved to be useful in supplying complementary 
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information compared to the designed 2-DE – MALDI-TOF/TOF approach. In particular, a large number 
of the identified proteins features basic pI and high molecular weight (Figure 3-10 and Figure 3-13). 
 
As a whole, the gel-based analyses of the salivary samples of healthy newborns led to the identification of 
a number of proteins linked to epidermal tissue functions and, more interestingly, some proteins involved 
in inflammatory processes (in particular annexin A1, glutathione S-transferase P, heat shock proteins, 
protein S100-A8 and -A9), evidence of a stressed condition in the early 48 hours after birth (Table 3-4 
and Table 3-5). 
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4.2. TARGETED ANALYSIS 
SAMPLE PREPARATION 
The most important step in the sample preparation for bottom-up proteomics studies is the efficient and 
reproducible cleavage of proteins into their constituent peptides. In most cases trypsin is the preferred 
proteolytic enzyme, thanks mainly to its high specificity. 
The most common steps in classical sample preparation protocols are schematized in Figure 4-1. Prior to 
protein digestion proteins need to be denatured, reduced and alkylated using various chemical reagents 
that are usually neither trypsin-tolerated nor MS-compatible, therefore sample purification procedures are 
required. Moreover, protein digestion is a time-consuming step in the sample preparation workflow since 
it typically consists in an overnight reaction at 37 °C with a trypsin to protein ratio between 1:100 and 
1:10. 
 
 
Figure 4-1. Scheme of the most common steps in sample preparation protocols. 
Denaturation and reduction can often be carried out simultaneously (e.g.: a combination of 
heat and a reducing reagent) and the following alkylation of cysteine residues is necessary to 
prevent re-oxidation of sulfhydryl groups. The protein, blocked in its denatured state, is 
exposed to the action of the proteolytic enzyme. 
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Among the different techniques developed with the aim to accelerate sample preparations and maximize 
the yield in proteotypic peptides there is the use of mixed organic-aqueous solutions. It has been 
demonstrated that solvent-assisted digestions often improve protein sequence coverage at shorter 
digestion times, due to an enhanced enzymatic activity of trypsin. Even though 20% is usually the 
maximum concentration recommended by the manufacturers in the product information sheets, trypsin is 
active even in 80% organic solvent (ACN or others). However, it has been reported that at solvent 
concentrations higher than 40% the risk of enzyme autolysis progressively increases, protein solubility 
generally decreases and multiple missed cleavages are more frequently observed [27, 30, 31, 57, 58]. 
A sample preparation protocol based on solvent-assisted protein digestion is schematized in Figure 4-2. 
 
 
Figure 4-2. Schematic of the main steps in accelerated sample preparation protocols. 
The choice of organic solvent and its concentration, the proper buffer, the adequate trypsin to 
protein ratio and the optimal duration of the digestion reaction, have to be experimentally 
determined for the target protein. 
 
Sample preparation in mixed organic-aqueous solution presents some relevant advantages: 
 it’s clean (the organic solvent represents a MS-compatible denaturing agent); 
 it’s fast (one hour of reaction is usually sufficient); 
 it’s cheap (use of chemical denaturing reagents and sample purification procedures is not required). 
 
In this work of thesis both the classical and the solvent-assisted digestion protocols were tested for the 
preparation of the three target acute-phase proteins calcitonin, procalcitonin and C-reactive protein. 
 
Digestions in aqueous solution 
Various sample preparations of the protein standards were tested, essentially differing in the denaturing 
step: the use of SDS and thermal denaturation was compared to the combination of urea and thiourea. 
Calcitonin 
Disruption of human calcitonin α-helical structure was possible only using the combination of urea and 
thiourea. The successive reduction and alkylation of the two Cys residues (disulfide bond between C1 and 
C7) in this reaction mixture resulted almost complete: only a small fraction of molecules was in the 
mono-alkylated state and there was no evidence of non-alkylated protein (Figure 3-17). The following 
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overnight digestion produced the two hCT constituent peptides leading to a sequence coverage of 100% 
(Figure 3-24). 
Procalcitonin 
Given the small quantity of protein standard at our disposal, only a protocol based on SDS and thermal 
denaturation was tested for human procalcitonin. A sequence coverage of 62.9% was obtained and the 
observed peptides are relative to the N- and C- terminal portions of the protein, whereas there is no trace 
of the two peptides in the central immature calcitonin region (Figure 3-34). It may be that, as previously 
noticed in the analysis of hCT standard, in the presence of SDS this region remains folded and the 
cleavage site is not accessible to the proteolytic enzyme. 
C-reactive protein 
Both the protocol of digestion based on urea denaturation and the one based on SDS and thermal 
denaturation produced the same sequence coverage (39.3%) in the analysis of human C-reactive protein 
(Figure 3-37 and Figure 3-47). The low coverage is mainly due to the presence of two long central 
portions of the protein (residues 70 – 114 and 124 – 188) lacking tryptic cleavage sites. 
Digestions in mixed organic-aqueous solvent systems 
Different protocols of digestion in mixed organic-aqueous solvent system were tested varying: 
 type and concentration of organic solvent: 
 60% acetonitrile / 40% 50 mM ammonium bicarbonate 
 80% acetonitrile / 20% 50 mM ammonium bicarbonate 
 60% methanol / 40% 50 mM ammonium bicarbonate 
 80% methanol / 20% 50 mM ammonium bicarbonate 
 trypsin to protein ratio: between 1:20 and 1:5 
 time: reactions were conducted for 15 – 90 minutes 
 alkylation of Cys residues: performed or not prior to digestion. 
Temperature (37 °C) and pH (8) were kept constant. 
Calcitonin 
In each of the solvent systems tested hCT essentially remained intact. Reduction of disulfide bonds and 
alkylation of Cys residues occurred to a variable extent depending on the type of organic solvent used and 
its concentration in the reaction mixture (Figure 3-49). The best results were obtained in the solvent 
system 60% ACN / 40% 50 mM ammonium bicarbonate, where hCT apparently adopts a conformation in 
which the Cys residues (N-terminal portion of the protein) are exposed to the solvent, whereas the unique 
cleavage site (Lys18) is hindered. The reduction of the ACN concentration to 20%, prior to the addition 
of trypsin in the reaction mixture, is likely to cause a change in hCT conformation since the cleavage site 
appears more exposed to the action of the proteolytic enzyme, but times longer than one hour are 
necessary for the reaction to be complete (Figure 3-50). 
Digestion of hCT in 60% ACN / 40% 50 mM ammonium bicarbonate with trypsin to protein ratio 1:5, 
without previous reduction of disulfide bonds and alkylation of Cys residues, was tested and monitored 
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over time: the protein remained essentially intact even after one hour of reaction, however little digestion 
was observed after 90 minutes (Figure 3-51). 
Procalcitonin 
Given the small quantity of protein standard at our disposal, only a protocol of abrupt digestion with 
trypsin to protein ratio 1:5 in 60% ACN / 40% 50 mM ammonium bicarbonate was tested for hPCT and 
monitored over time (Figure 3-58). A sequence coverage of 50% was obtained after one hour of reaction 
(Figure 3-59). The cleavage of the C-terminal peptide DMSSDLERDHRPHVSMPQNAN is particularly 
favored. Moreover it is interesting to note that the MALDI-TOF spectrum of the digestion solution 
reveals the presence of peptides belonging to the central portion of the protein, the calcitonin region, 
whereas it was previously demonstrated that in the same reaction solution hCT remains intact. 
C-reactive protein 
Since the solvent system 60% ACN / 40% 50 mM ammonium bicarbonate resulted to be the best suited 
for the analysis of hCT after reduction of disulfide bonds and alkylation of Cys residues, the same 
reaction mixture constituted the first choice for the analysis of hCRP. A sequence coverage of 31.6% was 
obtained after one hour of digestion with trypsin added in 1:5 ratio (Figure 3-66). As previously 
mentioned, the low sequence coverage obtained in the analysis of hCRP is mainly attributable to the 
presence of two long central portions of the protein (residues 70 – 114 and 124 – 188) lacking tryptic 
cleavage sites. Peptides RQDNEILIFWSK and ALKYEVQGEVFTKPQLWP, whose cleavage is 
particularly favored, are present even after just 15 minutes of reaction (Figure 3-67). 
Digestion of hCRP in 60% ACN / 40% 50 mM ammonium bicarbonate, without previous reduction of 
disulfide bonds and alkylation of Cys residues, was tested and monitored over time (Figure 3-68). Once 
again, a sequence coverage of 31.6% was obtained after one hour of reaction with trypsin added in 1:5 
ratio and the peptides of interest are present even after just 15 minutes of reaction. 
 
To sum up, digestion in the mixed organic-aqueous solvent system 60% ACN / 40% 50 mM ammonium 
bicarbonate with trypsin to protein ratio 1:5, one hour at 37 °C, without previous reduction of disulfide 
bonds and alkylation of Cys residues, appears suitable for the simultaneous analysis of the three proteins 
of interest: calcitonin can be detected as intact protein, whereas procalcitonin and C-reactive protein are 
cleaved into their constituent peptides, even after just 15 minutes of reaction. 
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CHARACTERISTICS OF THE PEPTIDES 
The peptides that are particularly favored in the aqueous solution are: 
 both N-terminal and C-terminal hCT constituent peptides C[alk]GNLSTC[alk]MLGTYTQDFNK 
(1 – 18) and FHTFPQTAIGVGAP (19 – 32); 
 hPCT peptide ASELEQEQER (38 – 47), C-terminal peptide DHRPHVSMPQNAN (104 – 116) 
and peptide SALESSPADPATLSEDEAR (5 – 23); 
 hCRP peptides ESDTSYVSLK (14 – 23) and GYSIFSYATK (48 – 57). 
On the other hand, the peptides that are particularly favored in the mixed organic-aqueous solvent system 
60% ACN / 40% 50 mM ammonium bicarbonate are: 
 intact hCT peptide CGNLSTCMLGTYTQDFNKFHTFPQTAIGVGAP (1 – 32); 
 hPCT C-terminal peptide DMSSDLERDHRPHVSMPQNAN (96 – 116); 
 hCRP C-terminal peptide ALKYEVQGEVFTKPQLWP (181 – 206); 
 hCRP peptide RQDNEILIFWSK (58 – 69). 
Analyzing the major physicochemical characteristics of the previously mentioned peptides, some general 
considerations can be inferred (Table 3-9). Missed cleavages are more frequently observed in the mixed 
organic-aqueous reaction mixture (up to two), therefore peptides are generally longer. Furthermore, 
peptides very often represent the C-terminal portion of the protein. hCRP peptides also present higher 
aliphatic indexes than the other peptides. The aliphatic index of a peptide is defined as the relative volume 
occupied by aliphatic side chains (alanine, valine, isoleucine and leucine) and may be regarded as a 
positive factor for the increase of thermostability. 
EVALUATION OF STATIONARY AND MOBILE PHASES 
Human calcitonin, procalcitonin and C-reactive protein standards digested in aqueous solutions were 
analyzed with a traditional HPLC fully porous column (BioBasic 18, 5 µm, 300 Å, 250 x 4.6 mm, 
Thermo Scientific). 
 
Later analyses of the same protein standards digested in mixed organic-aqueous solutions were performed 
after having tested a selection of new columns, suitable for both HPLC and UHPLC analyses, looking for 
the most fit for purpose stationary phase: three are based on the fused-core technology (Aeris Peptide XB-
C18, Ascentis Express Peptide ES-C18, Halo Peptide ES-C18), whereas one is characterized by the 
Charged-Surface Hybrid technology (XSelect CSH 130). 
The above-mentioned HPLC – UHPLC columns tested also feature smaller pore size (100 – 160 Å), 
optimized for the separation of peptides or small proteins up to 10 kDa. To allow fast and high-resolution 
separation of peptides, the pores must be large enough to permit efficient diffusion of peptide molecules 
in and out of the pores where they can fully interact with the bonded-phase. If the pore size is too small, 
there will be limited diffusion and the peptides will elute from the column with broad peaks, whereas, if 
the pore size is too large, there will be less surface area for peptides to interact with the bonded-phase, 
thus negatively affecting retention time, resolution, and sample capacity. 
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Figure 4-3. Comparison between fused-core and fully porous stationary phase particles. The most 
striking differences include: shorter diffusion path, narrower particle size distribution and therefore more 
consistent chromatographic bed. All these features lead to sharper peaks. From Ascentis Express HPLC 
columns brochure (Supelco). 
 
 
 
Figure 4-4. Comparison of Van Deemter plots of different HPLC columns. Fused-core HPLC – UHPLC 
columns are more efficient than columns packed with totally porous particles and that they can be run at 
higher mobile phase linear velocity and still maintain their resolving power. 
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With respect to the mobile phase, a methanol gradient was preferred to the acetonitrile gradient 
previously employed. Mobile phases were added with FA instead of TFA as modifier, since it facilitates 
more sensitive detection of peptides in ESI-MS peptide mapping analyses. 
 
Aeris Peptide XB-C18 (C18, 3.6 µm, 100 Å, 150 x 2.1 mm), Phenomenex. 
The stationary phase of this column is constituted by Core-Shell particles, that are characterized by the 
presence of a uniform porous silica layer, the 0.5 µm “shell”, grown around a solid silica sphere, the 
“core” of 2.6 µm of diameter (Figure 4-5). The thin porous layer is designed to decrease the diffusion 
path length compared to fully porous particles, thus reducing the time it takes for biomolecules to adsorb 
and desorb into and out of the particle and therefore minimizing band broadening. The dimension of the 
pores is optimized for the diffusion of peptides. Also the uniform size and shape of the particles, along 
with tight packing specifications, oppose to losses in efficiency and performance due to band broadening. 
 
 
Figure 4-5. Schematic picture of a Core-Shell stationary phase particle of Aeris Peptide column. 
 
Ascentis Express Peptide ES-C18 (C18, 2.7 µm, 160 Å, 150 x 4.6 mm), Sigma-Aldrich. 
The stationary phase of this column is constituted by Fused-Core particles (Figure 4-6). The short 
diffusion path (0.5 µm), the narrow particle size distribution and the homogeneity of the packed bed, aim 
at yielding sharp peaks and allowing high flow rates with reduced back pressure compared to the columns 
constituted by fully porous particles. Moreover, the extra stable (ES) C18 bonded-phase is sterically 
protected to guarantee high resistance to acid-catalyzed hydrolysis of the siloxane bond that attaches the 
C18 chain to the surface. Thus, the combination of low pH and elevated temperature of operation is well 
tolerated. 
 
 
Figure 4-6. Schematic picture of a stationary phase particle of Ascentis Express column. 
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Halo Peptide ES-C18 (C18, 2.7 µm, 160 Å, 150 x 2.1 mm), CPS Analitica. 
The stationary phase of this column is constituted by Fused-Core particles (Figure 4-7). 
 
 
Figure 4-7. Schematic picture of a stationary phase particle of Halo ES-C18 column. 
 
Halo columns generate fast separations with high resolving power thanks to the Fused-Core technology 
that creates a 0.5 μm porous shell fused to a solid core particle, which represents a small path for 
diffusion of solutes into and out of the stationary phase. The packing process of Fused-Core particles is 
facilitated for two reasons: particles have extremely narrow size distribution and, since those particles are 
significantly more dense than conventional totally porous particles, they are more easily packed into 
stable and efficient columns. 
The bonded C18 phase is extra stable (ES): the bulky side groups of organosilanes sterically protect the 
siloxane bond from acid hydrolysis and yield a stationary phase that is especially stable to the conditions 
typically used for the separation of peptides (Figure 4-8). 
 
 
Figure 4-8. Schematic illustration of the extra stable (ES) bonded phase. 
 
Moreover Halo columns are endowed with an inlet frit with a porosity that is significantly larger than 
other UHPLC columns (2 μm versus 0.5 μm) to prevent inlet plugging. 
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XSelect CSH 130 (C18, 2.5 µm, 130 Å, 150 x 4.6 mm), Waters. 
The stationary phase of this column is constituted by Charged Surface Hybrid (CSH) particles. CSH 
particles are generated via chemical bonding of a low-level charge to the surface of Ethylene-Bridged 
Hybrid (BEH) particles and successive C18 functionalization (end-capping) (Figure 4-9). 
 
 
Figure 4-9. Picture illustrating the sequential stages of production of stationary 
phase particles of CSH columns. 
 
The retention of peptides on XSelect CSH 130 C18 columns seems to be influenced by their charge (or 
charge density). Most tryptic peptides contain only two basic functional groups, one at the N-terminus 
and the other at the side chain of the C-terminal Lys/Arg residue. Peptides containing histidine residues or 
missed cleavage sites present additional positive charges and this causes shifts in retention times if 
compared to non-CSH columns. 
 
The evaluation of the four different HPLC – UHPLC columns was based on full scan analyses of hCT 
and hCRP digestion solutions on Synapt G2-S. Retention times and peak areas of the tryptic peptides of 
interest were monitored and compared. Given the small quantity of protein standard at our disposal, hPCT 
was later analyzed only with the column that gave the best results. 
The retentivity of peptides in the different columns varied (Table 3-11). The most retentive column was 
the Ascentis Express. For the rest, XSelect CSH 130 was more retentive than both the Halo and Aeris 
Peptide stationary phases. Also the elution order of two hCRP peptides changed in the XSelect column 
compared to the Halo and Aeris Peptide columns: peptide RQDNEILIFWSK eluted earlier than peptide 
ALKYEVQGEVFTKPQLWP. 
Regarding the peak areas of the peptides of interest, Halo Peptide and Aeris Peptide columns gave the 
best results for both hCRP C-terminal peptide ALKYEVQGEVFTKPQLWP and intact hCT (Figure 3-77 
and Figure 3-78). 
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MS/MS ANALYSES 
The type and relative abundance of different fragment ions in MS/MS spectra of a peptide depend on 
many factors, including the features of the peptide itself (presence/absence of basic amino acids, size, 
charge state), instrumentation and collision energy. Sequence ions b and y (also with loss of water or 
ammonia), internal ions and immonium ions are the most frequently observed in lower-energy collision-
induced dissociation (CID) spectra [59]. 
The mechanism proposed to explain the relationship between location of charges and fragmentation of 
protonated peptides is called “mobile proton model” (Figure 4-10). The model assumes that protons are 
initially localized at the most basic sites in the peptide, that is the N-terminus and the side chains of basic 
amino acid residues, particularly the C-terminal Arg/Lys in peptides originated by trypsin digestions. 
However, following activation, those protons show a high degree of internal solvation by the heteroatoms 
in the peptide, such as carbonyl oxygen and amino nitrogen, and proton transfer events may become 
possible, leading to a heterogeneous population of structures that fragment, finally generating the MS/MS 
spectra of the peptide [59, 60]. 
 
 
Figure 4-10. The mobile proton model. From Wysocki et al. [61]. 
 
In this work of thesis MS/MS analyses of the peptides of interest, originated by aqueous or mixed 
organic-aqueous digestions, were performed using one or more of the available mass spectrometers: 
 Q TRAP (LINAC Collision Cell and LIT); 
 Synapt G2-S (Trap/Transfer Cell); 
 MALDI-TOF/TOF (CID Cell). 
In ESI analyses fragmentation of peptides generated by digestions in aqueous solutions produced mainly 
y ions, whereas b ions were produced in MS/MS analyses of peptides whose cleavage is particularly 
favored in mixed organic-aqueous solutions. Both b and y ions were observed in MALDI-TOF/TOF 
analyses of the main hPCT and hCRP peptides generated in 60% ACN (Table 4-1). 
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Table 4-1. Table reporting the main type of fragments observed for each peptide in MS/MS analyses 
performed on different instruments. The peptides whose cleavage is particularly favored in aqueous solution 
or in mixed organic-aqueous solvent system are reported in blue and green respectively. 
Calibration curves 
Digestions in aqueous solution 
Table 4-2 summarizes the main features of the analyses of protein standards digested in aqueous solution 
in agreement to classical sample preparation protocols. 
 
 
Table 4-2. Table summarizing the main features of the calibration curves obtained for hCT and 
hCRP digested in aqueous solution. 
 
Tryptic digestion of hCT produces two peptides that mainly ionize in ESI as doubly-charged ions: the N-
terminal peptide C[alk]GNLSTC[alk]MLGTYTQDFNK and the C-terminal peptide 
FHTFPQTAIGVGAP (Figure 3-25). Linearity in the theoretical range of concentrations 0.5 – 50 µg/ml 
was tested and calibration curves were obtained (Figure 3-32 and Figure 3-33). 
Tryptic digestion of hCRP produces peptides that ionize in ESI as doubly-charged ions. The transitions of 
C-terminal peptide featured better linearity than those of the N-terminal peptide in the analyzed range 
most intense signals in Q1 full scan spectra are those of peptides ESDTSYVSLK and GYSIFSYATK 
(Figure 3-38). Linearity in the theoretical range of concentrations 2.5 – 50 µg/ml was tested and 
calibration curves were obtained (Figure 3-46). R
2
 values are ≥ 0.995 for each of the analyzed transitions 
of peptide ESDTSYVSLK. 
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Digestions in mixed organic-aqueous solvent systems 
The main features of the analyses of protein standards digested in organic-aqueous solution, without 
previous reduction of disulfide bonds and alkylation of Cys residues, are summarized in Table 4-3. 
 
 
Table 4-3. Table summarizing the main features of the calibration curves obtained for hCT and 
hCRP digested in 60% ACN. 
 
Tryptic digestion of hCT in 60% ACN actually leaves the protein undigested at least until after one hour 
of reaction (Figure 3-51), whereas the same sample preparation procedure applied to hCRP produces 
cleavage of the protein into its constituent peptides (Figure 3-69). 
Intact hCT mainly ionizes in ESI as triply-charged ion. Linearity in the theoretical range of concentrations 
0.1 – 12.5 µg/ml was tested and a calibration curve was obtained (Figure 3-57). R2 values are ≥ 0.995 for 
each of the analyzed transitions. 
Tryptic digestion of hCRP produces peptides that ionize in ESI as doubly-charged ions. The most intense 
signals in Q1 full scan spectra are those of peptides ALKYEVQGEVFTKPQLWP and RQDNEILIFWSK 
(data not shown). Linearity in the theoretical range of concentrations 2.5 – 50 µg/ml was tested and 
calibration curves were obtained (Figure 3-76Figure 3-46). The transitions of peptide RQDNEILIFWSK 
featured better linearity than those of peptide ALKYEVQGEVFTKPQLWP in the analyzed range. 
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ANALYSIS OF THE MATRIX EFFECT 
The general term matrix refers to the components of a sample other than the analyte. The matrix effect 
may be defined as the change (suppression or enhancement) in the LC-MS response of a specific analyte 
caused by co-eluting matrix compounds, compared to the analysis of the pure standard. The quantitative 
measure of matrix effects is the matrix factor (MF), defined as the ratio between the analyte peak 
response in the presence and in the absence of the matrix: MF = 1 indicates that there are no matrix 
effects, whereas MF < 1 indicates ion suppression and MF > 1 indicates ion enhancement. If matrix 
effects occur, they may affect the analytical method performance parameters such as limit of detection 
(LOD), limit of quantification (LOQ), linearity, accuracy and precision [62, 63]. 
 
Although the European Medicines Agency (EMEA) guidelines on bioanalytical method validation 
suggest the use of six lots of matrix from individual donors to investigate the matrix effect [64], in this 
work of thesis the preliminary experiments were carried out on a pooled matrix. 
Since proteins may act differently in different environments and less effective digestions are frequently 
observed when target proteins are digested in a mixture as compared to being digested separately [27], the 
evaluation of the matrix effect on the detection of the proteotypic peptides of hCT and hCRP was 
conducted by spiking a digested pooled sample with organic-aqueous digestion solutions of the protein 
standards. 
The pool, representative of healthy state, was analyzed soon after digestion in aqueous solution: 
calcitonin, procalcitonin and C-reactive protein, if present, were not detectable. Therefore the pool was 
separately spiked with the organic-aqueous digestion solutions of hPCT or hCRP, each at three 
concentration levels set in the medium-high range of the relative calibration curves (Figure 3-79 and 
Figure 3-80). MRM analyses followed and retention times and peak areas of the proteotypic peptides 
were monitored. 
 
The retention time of both intact hCT and the two hCRP peptides was increased in the spiked samples as 
compared with the reference values of the standards. Furthermore, the peaks relative to hCT appear 
broadened and pronged (Figure 3-81). This may be due to a combination of both matrix effect and 
column carryover. The latter represents a drawback affecting the Halo column, especially at the high 
analyte concentrations chosen in this test. 
The matrix factor (MF) was calculated for the analytes of interest: intact hCT and hCRP peptide 
ALKYEVQGEVFTKPQLWP showed a MF < 1 (suppression of analyte response) whereas hCRP peptide 
RQDNEILIFWSK showed a MF >1 (enhancement of analyte response) (Table 3-13 and Table 3-14). 
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In this work of thesis two gel-based bottom-up approaches were explored to characterize the protein 
content of whole saliva samples collected from healthy newborns in their early 48 hours after birth: 2D-
PAGE – MALDI-TOF/TOF and SDS-PAGE – LC-(HR)MS/MS. The two approaches proved to be 
feasible, considering the low amount of protein within the collected samples, and the results obtained 
were complementary. As a whole, the gel-based analyses of the salivary samples of healthy newborns led 
to the identification of a number of proteins linked to epidermal tissue functions, whose presence appears 
justified considering the sample collection procedure. More interestingly, some identifications were 
related to common proteins usually highly expressed and involved in inflammatory processes (in 
particular annexin A1, glutathione S-transferase P, heat shock proteins, protein S100-A8 and -A9), 
probable evidence of a stressed condition already detectable in the early 48 hours after birth. Future 
comparison between healthy newborns and newborns affected by bacterial infection will eventually 
highlight the differential expression of proteins and this will give new inputs to the development of 
innovative and noninvasive diagnostic methods for the early detection of EOS in newborns. 
 
Targeted analyses were focused on the development of an analytical method based on liquid 
chromatography coupled to mass spectrometry to qualitatively and quantitatively assay C-reactive 
protein, procalcitonin and calcitonin within salivary samples. Analytical MS-based methods present some 
undeniable advantages over immunochemical methods: high specificity, throughput multiplex analysis 
capable to monitor several analytes at the same time, investigation of structural modifications of proteins 
(e. g. post-translational modifications), fast method development and cheaper analyses. This study also 
enables to investigate the properties of newborn whole saliva samples as biological matrix for quantitative 
MS-based assays. Preliminary experiments on salivary samples showed the presence of a matrix factor in 
the determination of the proteins of interest. After having clarified the matrix effect, biological samples of 
newborns affected by bacterial infections will be analyzed to verify whether C-reactive protein and 
procalcitonin access to the oral fluid at detectable concentrations. 
The quantitative platform will be also applied to the determination of proteins highlighted as potential 
inflammatory markers depending upon the results of the untargeted analyses. 
 
Even though the bioanalytical platform has been applied to saliva samples, the developed methods and 
strategies can be adapted to other biological fluids. 
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6.1. GEL-BASED APPROACHES 
REAGENTS AND TOOLS 
Chemicals 
Acetic acid 
Agarose 
Ammonium bicarbonate (ABC) 
3-[(3-cholamidopropyl)dimethylammonium]-1-propanesulfonate (CHAPS) 
Formic acid (FA) 
Iodoacetamide (IAA) 
Dithioerythritol (DTE) 
Dithiothreitol (DTT) 
Glycerol 
Sodium dodecyl sulfate (SDS) 
Thiourea 
Trifluoroacetic acid (TFA) 
Tris•HCl 
Tris(2-carboxyethyl)phosphine hydrochloride (TCEP•HCl) 
Urea 
Water, LC-MS Ultra CHROMASOLV, tested for UHPLC-MS. 
All reagents are from SIGMA-ALDRICH. 
Preparative tools and devices 
ZipTip C18 Pipette Tips, Millipore 
Centrifuge 5430 R, Eppendorf 
CentriVap concentrator, Labconco 
Pipettes, Gilson 
Thermomixer comfort, Eppendorf 
Misonix Ultrasonic Processor XL-2020, Gilson Italia 
Ultrasonic Cleaner 5510, Branson 
Vortex, VWR International 
XP56 and XP205 balances, Mettler Toledo 
Solvents 
Acetone 
Acetonitrile 
Methanol 
All the solvents are from SIGMA-ALDRICH. 
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1D- and 2D-PAGE 
ReadyStrip ampholytes pH 3.9 – 5.1, pH 4.7 – 5.9 and pH 5.5 – 6.7 
Mineral oil 
2X Laemmli Sample Buffer 
10X Tris/Glycine Buffer 
Bio-Safe Coomassie Stain 
Silver Stain Plus kit 
7 cm Focusing Tray 
ReadyStrip IPG Strips, 7 cm, pH 4 – 7 
Protean IEF Cell 
Mini-PROTEAN TGX Precast Gels 
Mini-PROTEAN Tetra Cell 
11 cm Focusing Tray 
ReadyStrip IPG Strips, 11 cm, pH 4 – 7 
PROTEAN i12 IEF System 
Criterion TGX Precast Gels 
Criterion Electrophoresis Cell 
GS-800 densitometer 
ChemiDoc MP System 
All the 1D- and 2D-PAGE consumables and devices are from BIO-RAD. 
MALDI-TOF/TOF 
4800 MALDI-TOF/TOF, AB Sciex 
α-cyano-4-hydroxycinnamic acid, LaserBio Labs 
PepMix4, LaserBio Labs 
ProteoMass Peptide MALDI-MS Calibration Kit, SIGMA 
LTQ-Orbitrap XL 
LTQ-Orbitrap XL, Thermo Scientific 
UltiMate 3000 nano LC, Dionex 
Jupiter Proteo 4 µm, 90 Å, 250 x 0.30 mm, Phenomenex 
LC Packings, 30 µm (desalting), Dionex 
Software 
4000 Series Explorer, AB SCIEX 
GPS Explorer, AB Sciex 
Chromeleon, Thermo Scientific 
Xcalibur, Thermo Scientific 
Proteome Discoverer, Thermo Scientific 
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Online software 
Matrix Science: http://www.matrixscience.com/search_form_select.html 
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COLLECTION OF BIOLOGICAL SAMPLES 
The collection of whole unstimulated saliva is carried out by highly specialized staff of the Neonatology 
Unit at the Vaio Hospital in Fidenza (Parma). Gentle touches are applied with a sterile cotton swab, 
proven to be protein-free, inserted between the external surface of gingival walls and the cheek. 
Altogether, four swabs are collected for each newborn: the first pair of samples is collected within 24 
hours from birth and the second pair within the next 24 hours, at least two hours far from the meals. 
The freshly collected samples are stored at 4 °C in a Dewar for a maximum of 15' and then frozen at -80 
°C. The samples are transferred to Chiesi Farmaceutici using dry ice and stored at -20 °C prior to 
analysis. 
 
Permission of the Ethical Committee (“Comitato Etico Unico per la Provincia di Parma”) was obtained 
for the collection of salivary samples with unanimous favorable opinion (Protocol 35269, 24 September 
2012). Furthermore, written informed consent was obtained from parents. 
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EXTRACTION OF PROTEINS FROM SWABS 
Extraction of proteins from swabs 
Extraction of proteins to be analyzed in 2D-PAGE was performed with the following protocol: 
a) cut away the rod and put the swab into a 2 ml tube 
b) add 700 μl of freshly prepared extraction solution to completely cover the swab: 40 mM Tris•HCl, 
1% SDS, pH 7.4 
c) vortex for a few seconds 
d) submit to 3' of sonication (6 cycles of 30'' ON and 1' OFF) in an ultrasonic bath at 4 °C 
e) remove the swab and centrifuge the solution for 15' at 13,200 rpm and 4 °C 
f) separate the supernatant from the pellet and discard the latter 
g) add ice-cold acetone in 5:1 ratio and keep overnight at -20 °C 
h) centrifuge for 30' at 13,200 rpm and 4 °C to pellet the precipitated proteins 
i) discard the supernatant, then let the pellet dry out at room temperature 
j) re-solubilize the pellet in 100 μl of 2D-PAGE buffer: 7 M urea, 2 M thiourea, 4% CHAPS 
k) quantitate the protein amount in the extracted samples. 
Quantitation of the extracted protein amount 
The extracted protein amount was quantified before 2-DE analysis: 
a) dilute an aliquot of each sample in SDS-PAGE sample buffer 
b) SDS-PAGE: load the samples and PrecisionPlus Protein Standards (duplicate) 
c) ImageLab analysis of the gel and quantification of the extracted proteins. 
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2-DE – MALDI-TOF/TOF ANALYSES 
 
Single newborn analyses 
Sample preparation 
ReadyStrip IPG Strips, 7 cm, pH 4 – 7 
 
Total loading volume = 125 μl 
Protein quantity = 15 μg 
Rehydration buffer 
65 mM DTE 
0.5% ampholytes 
 
Isoelectric focusing 
Sample loading on IPG strip with active rehydration method (12 hours at 50 V). 
Isoelectric focusing process at 20 °C: 
 
Step Voltage (V) Time Mode 
1 250 15 minutes Rapid 
2 4000 1 hour Slow 
3 4000 V until 11000 V/h Rapid 
4 500 72 hours Rapid 
 
Equilibration 
The equilibration of the IPG strip prior to SDS-PAGE consisted of two steps: 
1) reduction in equilibration buffer with 1% DTE, 15 minutes at room temperature; 
2) alkylation in equilibration buffer with 4% IAA. 15 minutes in the dark at room temperature. 
SDS-PAGE 
The second dimension was carried out using Mini-PROTEAN TGX precast gels run at constant voltage 
(200 V). 
 
2-DE analyses of pools 
Sample preparation 
ReadyStrip IPG Strips, 11 cm, pH 4 – 7. 
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Total loading volume = 200 μl 
Protein quantity = 40 μg 
Rehydration buffer 
65 mM DTE 
0.5% ampholytes 
Pools were created collecting the same amount of protein from each single sample. 
Isoelectric focusing 
Sample loading on IPG strip with passive rehydration method. 
Isoelectric focusing process at 20 °C: 
Step Voltage (V) Time (hours) Mode 
1 0 16 Passive rehydration 
2 300 1 Rapid 
3 600 1 Rapid 
4 1000 1 Rapid 
5 4000 1 Rapid 
6 8000 1 Gradual 
7 8000 V until 26000 V/h 
8 500 72 Rapid 
Equilibration 
The equilibration of the IPG strip prior to SDS-PAGE consisted of two steps: 
1) reduction in equilibration buffer with 1% DTE, 15 minutes at room temperature; 
2) alkylation in equilibration buffer with 4% IAA. 15 minutes in the dark at room temperature. 
SDS-PAGE 
The second dimension was carried out using Criterion TGX precast gels run at constant voltage (200 V). 
Visualization of proteins 
Visualization of proteins on the 2-DE was carried out in 3 steps: 
3) Bio-Safe Coomassie staining 
4) destaining 
5) Silver staining. 
Spot excision and tryptic digestion 
The following digestion procedure was applied to the excised spots: 
a) gel destaining with a mixed solution of 30 mM potassium ferricyanide and 100 mM sodium 
thiosulfate in 1:1 ratio 
b) wash thoroughly with water to remove the destaining solution 
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c) add a mixed solution of ACN and 20 mM ammonium bicarbonate in 1:1 ratio and incubate for 20 
minutes 
d) remove the solution 
e) add 100% ACN and incubate for 5 minutes, then dry out the spot in a speed-vac for 5 minutes 
f) gel rehydration with trypsin solution for in-gel digestions, 15 minutes at room temperature 
g) remove the excess of trypsin solution 
h) addition of 20 mM ammonium bicarbonate to completely cover the spot 
i) in-gel digestion: 16 hours at 37 °C 
j) recovery of peptides: 
- recover the digestion solution 
- add 0.1% TFA and incubate at 37 °C for 45 minutes, then recover the solution 
- add ACN – 0.1% TFA in 1:1 ratio and incubate at 37 °C for 45 minutes, then recover the 
solution 
k) dry out the solution in a speed-vac 
l) solubilize the peptides just prior to MALDI-TOF/TOF analysis. 
 
MALDI-TOF/TOF analyses 
All of the samples were analyzed using an Applied Biosystems/MDS SCIEX 4800 MALDI TOF/TOF 
Analyzer. 
Peptide ion masses were measured with manual acquisition in the positive reflectron mode. 
Matrix: α-cyano-4-hydroxycinnamic acid (CHCA), 10 mg/ml in ACN – 0.1% TFA mixed 1:1. 
Sample preparation: dried droplet. 
External calibration was performed with either PepMix4 (500 – 3500 Da) or ProteoMass Peptide (700 – 
3500 Da) (Table 6-1 and Table 6-2). 
Table 6-1. PepMix4 calibration mixture. 
Standard Sequence 
Theoretical 
monoisotopic 
molecular weight 
Bradykinin fragment 1-5 RPPGF 572.31 
Human Angiotensin II DRVYIHPF 1045.53 
Neurotensin ZLYENKPRRPYIL 1672.92 
ACTH fragment 18-39 RPVKVYPNGAEDESAEAFPLEF 2464.19 
Insulin Chain B oxidized FVNQHLCGSHLVEALYLVCGERGFFYTPKA 3493.65 
 
Table 6-2. ProteoMass Peptide MALDI calibration mixture. 
Standard Sequence 
Theoretical 
monoisotopic 
molecular weight 
Bradykinin fragment 1-7 RPPGFSP 756.3997 
Human Angiotensin II DRVYIHPF 1045.5423 
P14R PPPPPPPPPPPPPPR 1532.8582 
ACTH fragment 18-39 RPVKVYPNGAEDESAEAFPLEF 2464.1989 
Insulin Chain B oxidized FVNQHLCGSHLVEALYLVCGERGFFYTPKA 3493.6513 
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Calibrations were accepted when they satisfied the following conditions: 
min S/N: 10 
mass tolerance: ± 10 ppm 
min peaks to match: 4 
max outlier error: ± 10 ppm 
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SDS-PAGE – LC-(HR)MS/MS ANALYSES 
 
SDS-PAGE analysis 
12% acrylamide gel run at constant voltage (200 V). 
Loaded sample quantity per lane = 10 µg. 
Bio-Safe Coomassie staining. 
Band excision and tryptic digestion 
Band excision and analysis: 
a) destaining with a solution 50% ethanol, 10% acetic acid 
b) wash: 10 minutes in water 
c) reduction in 1% DTE, 15 minutes 
d) alkylation in 4% IAA, 15 minutes in the dark 
e) 20 minutes in 80% ACN / 20% 20 mM ammonium bicarbonate 
f) 5 minutes in 100% ACN and then dry out the band in a speed-vac for 5 minutes 
g) gel rehydration with trypsin solution for in-gel digestions, 15 minutes at room temperature 
h) removal of the excess of trypsin solution 
i) addition of 20 mM ammonium bicarbonate to completely cover the band 
j) in-gel digestion: 16 hours at 37 °C 
k) recovery of peptides: 
- recover the digestion solution 
- add 0.1% TFA and incubate at 37 °C for 45 minutes, then recover the solution 
- add ACN – 0.1% TFA in 1:1 ratio and incubate at 37 °C for 15 minutes, then recover the 
solution. 
LC-(HR)MS/MS analyses 
Mass spectrometer: LTQ-Orbitrap XL. 
 
LC pump: Dionex UltiMate 3000 nano LC. 
Micro pump column: Jupiter Proteo 4 µm, 90 Å, 250 x 0.30 mm – Flow rate 5 µl/min. 
Loading pump column: LC Packings, 30 µm (desalting) – Flow rate 30 µl/min. 
 
Column oven: 45 °C. 
 
Mobile phases: 
A) 5% ACN, 0.1% FA, 0.01% TFA in H2O 
B) 5% H2O, 0.1% FA, 0.02% TFA in ACN 
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Mobile phase gradient (Figure 6-1): 
Time (min) % A % B 
0 95 5 
4 95 5 
34 50 50 
45 50 50 
62 5 95 
72 5 95 
84 95 5 
90 95 5 
 
 
Figure 6-1. Graph of the mobile phase gradient applied. 
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6.2. TARGETED ANALYSES 
REAGENTS AND TOOLS 
Proteins 
Human calcitonin, Sigma T3535 
Human procalcitonin, recombinant, expressed in E. coli, Sigma SRP6003 
Human C-reactive protein, recombinant, expressed in E. coli, Merck 236608 
Human C-reactive protein, RayBiotech, Inc. 228-10278-1 
Trypsin proteomics grade, Sigma T6567 
Chemicals 
Acetic acid 
Ammonium bicarbonate (ABC) 
Formic acid (FA) 
Iodoacetamide (IAA) 
Dithioerythritol (DTE) 
Dithiothreitol (DTT) 
Glycerol 
Sodium dodecyl sulfate (SDS) 
Thiourea 
Trifluoroacetic acid (TFA) 
Tris•HCl 
Tris(2-carboxyethyl)phosphine hydrochloride (TCEP•HCl) 
Urea 
Water, LC-MS Ultra CHROMASOLV, tested for UHPLC-MS. 
All reagents are from SIGMA-ALDRICH. 
Preparative tools and devices 
ZipTip C18 Pipette Tips, Millipore 
Pierce C18 Spin Columns, Thermo Scientific 
Micro Bio-Spin Chromatography Columns, BIO-RAD 
PD MiniTrap G-10, GE Healthcare 
Pierce Detergent Removal Spin Columns, Thermo Scientific 
Pipettes, Gilson 
Centrifuge 5430 R, Eppendorf 
CentriVap concentrator, Labconco 
Thermomixer comfort, Eppendorf 
Ultrasonic Cleaner 5510, Branson 
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Vortex, VWR International 
XP56 and XP205 balances, Mettler Toledo 
Solvents 
Acetone 
Acetonitrile 
Methanol 
All the solvents are from SIGMA-ALDRICH. 
MALDI-TOF/TOF 
4800 MALDI-TOF/TOF, AB Sciex 
α-cyano-4-hydroxycinnamic acid, LaserBio Labs 
PepMix3, LaserBio Labs 
PepMix4, LaserBio Labs 
ProteoMass Peptide MALDI-MS Calibration Kit, SIGMA 
LC columns 
BioBasic 18 column, 5 μm, 250 x 4.6 mm, Thermo Scientific 
Aeris Peptide UHPLC/HPLC column, 3.6 μm, 150 x 2.1 mm, Phenomenex 
Ascentis Express C18 HPLC column, 2.7 μm, 150 x 4.6 mm, SIGMA 
HALO ES-C18 UHPLC column, 2.7 μm, 150 x 2.1 mm, Bruker-Michrom 
XSelect CSH 130 column, 2.5 μm, 150 x 4.6 mm, Waters 
LC-MS instruments 
HPLC HP1100, Agilent 
4000 QTRAP, AB Sciex 
UPLC Acquity, Waters 
Synapt G2-S, Waters 
Software 
4000 Series Explorer, AB SCIEX 
Analyst 1.5, AB Sciex 
MRM Pilot, AB Sciex 
MultiQuant, AB Sciex 
MassLynx, Waters 
BiopharmaLynx, Waters 
Online software 
ExPASy Compute pI/Mw: http://web.expasy.org/compute_pi/ 
ExPASy FindPept: http://web.expasy.org/findpept/ 
6. Experimental section 
153 
 
ExPASy Peptide Cutter: http://web.expasy.org/peptide_cutter/ 
ExPASy ProtParam: http://web.expasy.org/protparam/ 
Fragment ion calculator: http://db.systemsbiology.net/proteomicsToolkit/FragIonServlet.html 
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PURIFICATION PROCEDURES 
Reverse-phase chromatography 
ZipTip C18 Pipette Tips (Millipore) 
1) prepare the following solutions: 
Solution Composition 
Wetting 100% ACN 
Equilibration 0.1% TFA in H2O 
Wash 0.1% TFA in H2O 
Elution 100% ACN – 0.1% TFA in H2O mixed 1:1 
2) add 0.1% TFA to the sample solution 
3) equilibration of the ZipTip Pipette Tip for sample binding: 
a) aspirate 10 µl of wetting solution and dispense to waste 
b) repeat 
c) aspirate equilibration solution and dispense to waste 
d) repeat 
4) binding of the peptides/protein to the resin: aspirate and dispense the sample (7 – 10 cycles) 
5) sample wash: aspirate the wash solution and dispense to waste, then repeat at least once 
6) sample elution: 
a) dispense a desired volume of elution solution into a clean vial 
b) aspirate and dispense the elution solution through the ZipTip within the vial 
c) repeat at least three times. 
Pierce C18 Spin Columns (Thermo Scientific) 
1) prepare the following solutions: 
solution composition total volume (µl) 
Activation 50% methanol 400 
Equilibration 0.5% TFA in 5% ACN 400 
Sample 0.5% TFA in 5% ACN 10 – 150 
Wash 0.5% TFA in 5% ACN 800 – 1200 
Elution 0.1% FA in 70% ACN 40 
2) column preparation: 
a) tap the column to settle the resin 
b) remove top e and bottom cap and place the column in a 1.5ml tube 
c) add 200 µl of activation solution to rinse the walls of the column and wet the resin 
d) centrifuge at 1,500 x g for 1', then discard the flow-through 
e) repeat once 
3) column equilibration: 
a) add 200 µl of equilibration solution 
b) centrifuge at 1,500 x g for 1', then discard the flow-through 
c) repeat once 
4) sample binding: 
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a) load sample on top of the resin bed 
b) place the column in a receiver tube 
c) centrifuge at 1,500 x g for 1' 
d) recover the flow-through, reload it and centrifuge again at 1,500 x g for 1' 
5) sample wash: 
a) place the column in a receiver tube 
a) add 200 µl of wash solution, then centrifuge at 1,500 x g for 1' 
b) repeat once or twice 
6) sample elution: 
a) place the column in a new receiver tube 
b) add 20 µl of elution solution, then centrifuge at 1,500 x g for 1' 
c) repeat once using the same receiver tube. 
Size exclusion chromatography 
Micro Bio-Spin Chromatography Columns (BIO-RAD) 
1) prepare the column: 
a) resuspend the gel and remove air bubbles by inverting the column sharply several times 
b) snap off the tip and place the column in a 2 ml tube, then remove the top cap 
c) allow the excess packing buffer to drain by gravity and discard it 
d) centrifuge for 2' at 1,000 x (g) to remove the remaining buffer and discard it 
2) column equilibration: 
a) apply 500 µl of the desired buffer, centrifuge for 1' at 1,000 x (g) and discard the flow-through 
b) repeat the previous step for at least three times 
3) sample application and elution: 
a) place the column in a clean 1.5 or 2 ml tube and apply the sample (20 – 75 µl) 
b) centrifuge for 4' at 1,000 x (g) to recover the sample in the new buffer. 
PD MiniTrap G-10 columns (GE Healthcare) 
1) prepare the column: 
a) invert the column several times to resuspend the medium in the storage solution 
b) allow the medium to settle 
c) remove the top and bottom caps and allow the storage solution to drain by gravity 
2) column equilibration: 
a) fill the column with the desired equilibration buffer and allow it to flow out 
b) repeat at least twice 
3) sample application: 
a) add maximum 0.3 ml of sample and let it enter the packed bed completely 
b) add a stacker volume of equilibration buffer so that the total volume of sample and buffer 
equals 0.7 ml and let it enter the packed bed completely 
4) sample elution: 
a) place a clean tube under the column 
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b) add 0.5 ml of buffer and collect the eluate. 
Others 
Pierce Detergent Removal Spin Columns (Thermo Scientific) 
1) column preparation: 
a) remove the bottom cap and loosen the top one 
b) place the column into a 2 ml tube 
c) centrifuge at the speed and time indicated to remove the storage solution 
2) column equilibration: 
a) add the equilibration buffer and centrifuge 
b) repeat at least twice 
3) sample application: 
a) place the column in a clean 1.5 ml collection tube 
b) slowly apply the sample to the top of the compact resin bed 
c) incubate for 2' at room temperature 
4) sample elution: centrifuge for 2' at the indicated speed. 
 Column size (µl) 
 125 500 
solutions 
Sample volume range (µl) 10 – 25 25 – 100 
Equilibration solution (µl) 100 400 
centrifuge 
Speed (g) 1000 1500 
Time (min): 
- storage solution removal 1 1 
- washes 1 1 
- sample recovery 2 2 
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MALDI-TOF/TOF 
All of the samples were analyzed using an Applied Biosystems/MDS SCIEX 4800 MALDI TOF/TOF 
Analyzer. 
 
Peptide ion masses were measured with manual acquisition in the positive reflectron mode. 
 
Matrix: α-cyano-4-hydroxycinnamic acid (CHCA), 10 mg/ml in ACN – 0.1% TFA mixed 1:1. 
 
Sample preparation: dried droplet. 
 
External calibration was performed with one of the following calibration mixtures, depending on the 
expected mass of the analytes: PepMix3 (3000 – 9000 Da), PepMix4 (500 – 3500 Da) or ProteoMass 
Peptide (700 – 3500 Da) (Table 6-3, Table 6-4, Table 6-5). 
 
Table 6-3. PepMix3 calibration mixture. 
Standard Sequence 
Theoretical 
monoisotopic 
molecular weight 
Insulin Chain B oxidized FVNQHLCGSHLVEALYLVCGERGFFYTPKA 3493.65 
Insulin (bovine) 
GIVEQCCASVCSLYQLENYCN-
FVNQHLCGSHLVEALYLVCGERGFFYTPKA 
5733.49 
Aprotinin 
RPDFCLEPPYTGPCKARIIRYFYNAKAGLCQTFVYGGC
RAKRNNFKSAEDCMRTCGGA 
6511.44 
Ubiquitin (bovine) 
MQIFVKTLTGKTITLEVEPSDTIENVKGKIQEKEGIPPD
QQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGG 
8559.62 
 
Table 6-4. PepMix4 calibration mixture. 
Standard Sequence 
Theoretical 
monoisotopic 
molecular weight 
Bradykinin fragment 1-5 RPPGF 572.31 
Human Angiotensin II DRVYIHPF 1045.53 
Neurotensin ZLYENKPRRPYIL 1672.92 
ACTH fragment 18-39 RPVKVYPNGAEDESAEAFPLEF 2464.19 
Insulin Chain B oxidized FVNQHLCGSHLVEALYLVCGERGFFYTPKA 3493.65 
 
Table 6-5. ProteoMass Peptide MALDI calibration mixture. 
Standard Sequence 
Theoretical 
monoisotopic 
molecular weight 
Bradykinin fragment 1-7 RPPGFSP 756.3997 
Human Angiotensin II DRVYIHPF 1045.5423 
P14R PPPPPPPPPPPPPPR 1532.8582 
ACTH fragment 18-39 RPVKVYPNGAEDESAEAFPLEF 2464.1989 
Insulin Chain B oxidized FVNQHLCGSHLVEALYLVCGERGFFYTPKA 3493.6513 
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Calibrations were accepted when they satisfied the following conditions: 
min S/N: 10 
mass tolerance: ± 10 ppm 
min peaks to match: 4 
max outlier error: ± 10 ppm 
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HPLC – Q TRAP 
 
Analyses of protein standards digested in aqueous solution 
 
HPLC pump: Agilent 1100. 
 
HPLC column: BioBasic 18 (Thermo Scientific), 250 x 4.6 mm, 5 µm. 
Column oven: 45 °C. 
 
Mobile phases: 
A) 5% ACN, 0.1% FA, 0.02% TFA in H2O 
B) 5% H2O, 0.1% FA, 0.02% TFA in ACN 
 
Mobile phase flux = 250 µl/min. 
 
Mobile phase gradient “Biobasic_2” (Figure 6-2): 
Time (min) % A % B 
0 95 5 
8 95 5 
15 50 50 
25 50 50 
35 5 95 
40 5 95 
46 95 5 
65 95 5 
 
 
Figure 6-2. Mobile phase gradient “Biobasic_2”. 
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Mobile phase gradient “Biobasic_3” (Figure 6-3): 
Time (min) % A % B 
0 95 5 
8 95 5 
15 50 50 
20 50 50 
40 5 95 
45 5 95 
50 95 5 
65 95 5 
 
 
Figure 6-3. Mobile phase gradient “Biobasic_3”. 
 
Ion source: Turbo V Ion Source. 
y-axis probe position = 2 
Source parameters: 
Curtain gas (CUR): 30 
CAD: High 
Ion Spray Voltage (IS): 5500 
Temperature (TEM): 550 
Gas 1 (GS1): 50 
Gas 2 (GS2): 40 
 
Injection volume = 20 µl 
 
Analyses of protein standards digested in organic-aqueous solutions 
 
HPLC pump: Agilent 1100 
HPLC column: HALO ES-C18 UHPLC column, 2.7 μm, 150 x 2.1 mm, Bruker-Michrom 
Column oven: 65 °C 
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Mobile phases: 
A) 0.1% FA in H2O 
B) 0.1% FA in MeOH 
Mobile phase flux = 250 µl/min 
 
Mobile phase gradient (Figure 6-4): 
Time (min) % A % B 
0 99 1 
5 99 1 
15 69 31 
15.2 68 32 
35 10 90 
50 99 1 
75 99 1 
 
 
Figure 6-4. Mobile phase gradient applied in the analyses of protein 
standards digested in organic-aqueous solutions. 
 
Ion source: Turbo V Ion Source 
 
y-axis probe position = 2 
 
 
Source parameters: 
Curtain gas (CUR): 30 
CAD: High 
Ion Spray Voltage (IS): 5500 
Temperature (TEM): 550 
Gas 1 (GS1): 50 
Gas 2 (GS2): 40 
Injection volume = 5 µl 
 
  
6. Experimental section 
162 
 
UPLC – SYNAPT 
UPLC pump: Waters Acquity 
 
UPLC columns tested: 
Column name SP Particle size 
(μm) 
Pore size 
(Å) 
Length 
(mm) 
I. D. 
(mm) 
Brand 
Aeris Peptide C18 3.6 100 150 2.1 Phenomenex 
Ascentis Express C18 2.7 160 150 4.6 SIGMA 
HALO ES-C18 C18 2.7 160 150 2.1 CPS 
XSelect CSH 130 C18 2.5 130 150 4.6 Waters 
 
Column oven: 65 °C 
 
Mobile phases: 
A) 0.1% FA in H2O 
B) 0.1% FA in methanol 
 
Mobile phase flux = 200 µl/min 
 
Mobile phase gradient (Figure 6-4): 
Time (min) % A % B 
0 99 1 
5 99 1 
15 69 31 
15.2 68 32 
35 10 90 
50 99 1 
75 99 1 
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MRM ANALYSES 
Protein standards digested in aqueous solution 
 
Intact calcitonin 
The transitions analyzed are reported in Table 6-6. 
 
Table 6-6. MRM transitions of intact hCT. 
m/z 
precursor ion 
(Q1) 
m/z 
fragment ion 
(Q3) 
Fragment ion DP CE 
Time 
(msec) 
1179.0 1711.0 y32(2+) 80 50 100 
1179.0 1569.0 y15(1+) 80 50 100 
1179.0 1141.0 y32(3+) 80 50 100 
1179.0 1249.0 y23(2+) 80 50 100 
1179.0 910.0 y10(1+) 80 50 100 
 
Linearity in the theoretical range of concentrations 0.4 – 50 µg/ml was tested (HPLC gradient 
“biobasic_2”) using four solutions generated through successive dilutions of the digestion solution 
(Figure 6-5). 
 
Figure 6-5. Scheme of the successive dilutions of the digestion solution, reporting 
the injected protein quantities. 
 
Digested calcitonin 
The transitions analyzed are reported in Table 6-7. 
Table 6-7. MRM transitions of digested hCT. 
m/z 
precursor ion 
(Q1) 
m/z 
fragment ion 
(Q3) 
Fragment ion DP CE 
Time 
(msec) 
721.9 1328.2 b13(1+) 70 30 100 
721.9 665.0 b13(2+) 70 30 100 
721.9 629.4 b5(1+) 70 30 100 
1056.0 1074.3 y9(1+) 70 50 100 
1056.0 1187.2 y10(1+) 70 50 100 
1056.0 753.2 y6(1+) 70 50 100 
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Linearity in the theoretical range of concentrations 0.5 – 50 µg/ml was tested (HPLC gradient 
“biobasic_2”) using five solutions generated through successive dilutions of the digestion solution (Figure 
6-6). 
 
 
Figure 6-6. Scheme of the successive dilutions of the digestion solution, reporting the injected 
protein quantities. 
 
Three independent replicas for each concentration were generated and then analyzed. 
 
C-reactive protein 
The transitions analyzed are reported in Table 6-8. 
 
Table 6-8. MRM transitions of digested hCRP. 
m/z 
precursor ion 
(Q1) 
m/z 
fragment ion 
(Q3) 
Fragment ion DP CE 
Time 
(msec) 
565.0 609.8 y5(1+) 70 25 100 
565.0 696.8 y6(1+) 70 25 100 
565.0 913.0 y8(1+) 70 25 100 
565.0 797.9 y7(1+) 70 25 100 
569.8 918.1 y8(1+) 60 30 100 
569.8 717.1 y6(1+) 60 30 100 
569.8 831.0 y7(1+) 60 30 100 
 
Linearity in the theoretical range of concentrations 2.5 – 50 µg/ml was tested (HPLC gradient 
“biobasic_3”) using five solutions generated through successive dilutions of the digestion solution (Figure 
6-7). 
 
 
Figure 6-7. Scheme of the successive dilutions of the digestion solution, reporting the injected 
protein quantities. 
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Protein standards digested in mixed organic-aqueous solvent system 
 
Intact calcitonin 
The transitions analyzed are reported in Table 6-9. 
Table 6-9. MRM transitions of intact hCT. 
m/z 
precursor ion 
(Q1) 
m/z 
fragment ion 
(Q3) 
Fragment ion DP CE 
Time 
(msec) 
1141.2 1654.0 b31(2+) 70 35 100 
1141.2 1103.4 b31(3+) 70 35 100 
1141.2 1079.8 b30(3+) 70 35 100 
 
Linearity in the theoretical range of concentrations 0.1 – 12.5 µg/ml were tested using five solutions 
generated through successive dilutions of the digestion solution (Figure 6-8). 
 
 
Figure 6-8. Scheme of the successive dilutions of the digestion solution, reporting the injected protein 
quantities. 
 
Three independent replicas for each concentration were generated and then analyzed. 
 
C-reactive protein 
The transitions analyzed are reported in Table 6-10. 
Table 6-10- MRM transitions of digested hCRP. 
m/z 
precursor ion 
(Q1) 
m/z 
fragment ion 
(Q3) 
Fragment ion DP CE 
Time 
(msec) 
776.7 1130.4 b9(1+) 100 43 100 
776.7 870.1 b7(1+) 100 43 100 
776.7 983.3 b8(1+) 100 43 100 
712.9 917.5 b16(2+) 75 27 100 
712.9 1010.7 b17(2+) 75 27 100 
712.9 1118.1 b10(1+) 75 27 100 
 
Linearity in the theoretical range of concentrations 2.5 – 50 µg/ml were tested using five solutions 
generated through successive dilutions of the digestion solution (Figure 6-9). 
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Figure 6-9. Scheme of the successive dilutions of the digestion solution, reporting the injected protein 
quantities. 
 
Three independent replicas for each concentration were generated and then analyzed. 
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COLLECTION OF BIOLOGICAL SAMPLES 
 
The collection of whole unstimulated saliva is carried out by highly specialized staff of the Neonatology 
Unit at the Vaio Hospital in Fidenza (Parma). Gentle touches are applied with a sterile cotton swab, 
proven to be protein-free, inserted between the external surface of gingival walls and the cheek. 
Altogether, four swabs are collected for each newborn: the first pair of samples is collected within 24 
hours from birth and the second pair within the next 24 hours, at least two hours far from the meals. 
The freshly collected samples are stored at 4 °C in a Dewar for a maximum of 15' and then frozen at -80 
°C. 
The samples are transferred to Chiesi Farmaceutici using dry ice and stored at -20 °C prior to analysis. 
 
Permission of the Ethical Committee (“Comitato Etico Unico per la Provincia di Parma”) was obtained 
for the collection of salivary samples with unanimous favorable opinion (Protocol 35269, 24 September 
2012). Furthermore, written informed consent was obtained from parents. 
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SAMPLE PREPARATION AND LC-MS/MS ANALYSIS 
Extraction of proteins from swabs and creation of a pooled sample 
Extraction of proteins to be pooled and analyzed in LC-MS/MS was performed with the following 
protocol: 
a) cut away the rods and put the swabs into 2 ml tubes 
b) add 700 μl of freshly prepared extraction solution in each tube to completely cover the swab: 40 
mM Tris•HCl, 1% SDS, pH 7.4 
c) vortex the tubes for a few seconds 
d) submit to 3' of sonication (6 cycles of 30'' ON and 1' OFF) in an ultrasonic bath at 4 °C 
e) remove the swabs and centrifuge the extraction solutions for 15' at 13,200 rpm and 4 °C 
f) separate the supernatant from the pellet and discard the latter 
g) merge the extraction solutions and then divide in aliquots 
h) add ice-cold acetone in 5:1 ratio and keep overnight at -20 °C 
i) centrifuge for 30' at 13,200 rpm and 4 °C to pellet the precipitated proteins 
j) discard the supernatant, then let the pellets dry out at room temperature 
k) store the pellets at -20 °C. 
Quantitation of the extracted protein amount 
The extracted protein amount was quantified before digestion: 
a) re-solubilize an aliquot in SDS-PAGE sample buffer 
b) SDS-PAGE: load the pooled sample and PrecisionPlus Protein Standards (duplicate) 
c) ImageLab analysis of the gel for the quantification of the extracted proteins. 
Digestion of the pooled sample for LC-MS/MS analysis 
Protocol for the digestion of the pooled sample prior to LC-MS/MS analysis: 
- thaw the pelleted sample stored at -20 °C 
- solubilize the pellet in 50 mM ammonium bicarbonate, 0.1% SDS 
- in-solution digestion: 16 hours at 37 °C with trypsin 1:20 (w/w) 
- quenching of digestion by addition of 0.1% formic acid. 
Digestion of the protein standards in organic-aqueous solution 
Human calcitonin and human C-reactive protein were digested separately: 
- dilution of the stock solution to 0.1 mg/ml with 60% ACN / 40% ammonium bicarbonate 
- in-solution digestion: 1 hour at 37 °C with trypsin 1:5 (w/w) 
- quenching of digestion by addition of 0.1% formic acid. 
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MRM analyses 
The pool created from five healthy newborns on their second day after birth and digested in aqueous 
solution was analyzed to verify if the proteins of interest, calcitonin, procalcitonin and C-reactive protein, 
were present and detectable. The transitions monitored are reported in Table 6-11. 
Table 6-11. Transitions monitored in the analysis of the pool representative of healthy state. 
PROTEIN 
m/z 
precursor ion 
(Q1) 
m/z 
fragment ion 
(Q3) 
Fragment ion DP CE 
Time 
(msec) 
hCT 
1179.0 1711.0 y32(2+) 80 50 100 
1179.0 1569.0 y15(1+) 80 50 100 
1179.0 1141.0 y32(3+) 80 50 100 
721.9 1328.2 b13(1+) 70 30 100 
721.9 665.0 b13(2+) 70 30 100 
721.9 629.4 b5(1+) 70 30 100 
hPCT 
609.9 818.9 y6(1+) 60 35 100 
609.9 690.0 y5(1+) 60 35 100 
974.5 1089.4 y10(1+) 60 40 100 
974.5 1372.8 y13(1+) 60 40 100 
hCRP 
565.0 609.8 y5(1+) 70 25 100 
565.0 696.8 y6(1+) 70 25 100 
565.0 797.9 y7(1+) 70 25 100 
569.8 918.1 y8(1+) 60 30 100 
569.8 717.1 y6(1+) 60 30 100 
569.8 831.0 y7(1+) 60 30 100 
 
The pool was separately spiked with the organic-aqueous digestion solutions of hPCT or hCRP and MRM 
analyses followed. The transitions monitored are reported in Table 6-12. 
Table 6-12. Transitions monitored in the analysis of the pool representative of healthy state. 
PROTEIN 
m/z 
precursor ion 
(Q1) 
m/z 
fragment ion 
(Q3) 
Fragment ion DP CE 
Time 
(msec) 
hCT 
1141.2 1654.0 b31(2+) 70 35 100 
1141.2 1103.4 b31(3+) 70 35 100 
1141.2 1079.8 b30(3+) 70 35 100 
hPCT 
813.0 769.5 b20(3+) 90 35 100 
813.0 948.2 b16(2+) 90 35 100 
813.0 1050.4 b9(1+) 90 35 100 
hCRP 
776.7 1130.4 b9(1+) 100 43 100 
776.7 870.1 b7(1+) 100 43 100 
776.7 983.3 b8(1+) 100 43 100 
712.9 917.5 b16(2+) 75 27 100 
712.9 1010.7 b17(2+) 75 27 100 
712.9 1118.1 b10(1+) 75 27 100 
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